data_2hfr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hfr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.9 t -77.83 -48.13 2.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.772 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 82.6 Cg_endo -78.01 -18.21 13.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.237 1.958 . . . . 0.0 112.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.17 -2.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.742 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.78 -22.75 25.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.656 0.265 . . . . 0.0 111.489 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 11' ' ' ILE . 21.5 mt -87.08 12.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.727 0.299 . . . . 0.0 111.78 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -108.05 -29.05 9.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 110.268 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -109.99 -26.69 9.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -87.73 -29.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.22 73.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.28 85.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.247 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.422 -180.0 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.6 t -77.26 -47.72 2.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.97 -2.68 12.89 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.249 1.966 . . . . 0.0 112.983 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -98.89 -35.69 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -28.95 14.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.17 17.39 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -106.96 -31.6 8.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.888 0.375 . . . . 0.0 110.436 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -117.73 -22.12 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.308 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.8 -23.97 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.59 85.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.362 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.1 90.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.554 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.459 -0.021 0 CA-C-O 120.779 0.323 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 t -59.08 -48.23 96.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.85 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 70.9 Cg_endo -75.76 -45.74 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.162 1.908 . . . . 0.0 112.755 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.8 -11.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.692 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 -34.78 63.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 111.372 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mm -87.03 14.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.812 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.97 -30.73 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.403 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.3 m -114.71 -19.58 11.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.275 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 t -96.69 -23.99 4.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.854 0.359 . . . . 0.0 111.023 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.92 82.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.56 -18.31 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.735 -179.735 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.768 0.318 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 39.6 t -73.62 -49.32 6.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.504 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 66.2 Cg_endo -74.03 -25.95 13.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.241 1.961 . . . . 0.0 112.322 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.97 -20.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.211 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.72 4.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 pt -87.01 15.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.43 -31.84 8.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.421 . . . . 0.0 110.096 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -109.89 -28.54 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.677 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 -27.8 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.3 67.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.45 76.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.301 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.762 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.6 t -79.69 -48.16 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.7 Cg_exo -71.01 -28.9 18.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.637 2.225 . . . . 0.0 112.142 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.62 -6.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.699 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.88 -24.57 16.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 tt -85.03 10.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.12 -31.64 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 110.053 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.6 m -104.99 -28.06 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.7 t -88.4 -26.79 5.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.66 -32.88 47.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.15 -8.95 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.706 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.349 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.713 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.933 0.397 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 t -64.46 -54.35 38.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.717 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 11.9 Cg_endo -55.58 -21.78 32.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.294 1.996 . . . . 0.0 112.751 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.6 -31.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.238 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -49.85 -35.17 22.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.67 20.41 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -108.26 -36.18 6.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.509 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 m -121.19 -12.73 8.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 2.8 t -104.96 -16.58 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.6 60.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.91 -25.53 30.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.538 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.927 -179.657 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t -77.03 -48.24 2.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.411 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 89.1 Cg_endo -81.85 -26.04 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.376 2.051 . . . . 0.0 112.519 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.0 -36.56 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.065 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -51.61 -36.36 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -83.71 10.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.588 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -107.41 -31.6 8.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.041 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.8 m -107.58 -27.13 10.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.676 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 15.0 t -91.22 -3.53 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.078 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.69 -38.31 5.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.2 63.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.381 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.575 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 t -86.69 -48.61 0.5 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 62.8 Cg_endo -88.8 14.3 2.3 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.724 2.283 . . . . 0.0 112.897 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.99 -26.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.589 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.27 -36.29 30.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 mp -84.74 12.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.685 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -106.33 -31.56 8.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 110.15 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 m -110.34 -27.58 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.711 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 18.9 t -89.26 -26.31 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.65 -11.87 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.644 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.51 -31.75 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 111.519 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.805 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t -82.17 -48.84 0.9 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 98.1 Cg_endo -84.47 -26.46 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.076 . . . . 0.0 112.438 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.54 -29.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.68 -42.85 57.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.24 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.18 9.7 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.65 -29.75 8.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.224 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 m -113.36 -23.13 10.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 6.4 t -96.59 -25.8 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.7 74.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.84 -38.81 53.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.328 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.576 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.545 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -66.92 -52.36 32.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.814 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 25.6 Cg_endo -62.06 -15.82 46.16 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.639 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.56 -28.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.62 -36.73 36.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.273 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 pt -84.7 12.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.779 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -107.95 -31.82 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.419 . . . . 0.0 110.105 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -109.94 -25.03 10.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.76 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 14.3 t -94.26 -28.44 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.954 0.407 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 -38.72 54.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 -19.69 59.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.567 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 4.8 t -83.41 -45.01 0.83 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.622 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 25.8 Cg_exo -62.56 -39.87 41.89 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.537 2.158 . . . . 0.0 112.57 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.64 -5.46 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.816 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.09 -21.21 45.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.251 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.33 13.46 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.751 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -108.86 -28.94 8.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.549 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -106.16 -25.72 11.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.08 -40.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.154 0.502 . . . . 0.0 110.557 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.46 -29.85 70.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.12 -27.15 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.611 -179.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.1 t -85.2 -46.55 0.64 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.447 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 16.7 Cg_exo -67.5 -25.33 41.38 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.511 2.14 . . . . 0.0 112.38 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.93 -45.7 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.27 -47.4 36.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.244 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.06 12.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.632 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.42 -31.53 9.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.153 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -117.57 -24.76 7.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.224 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 13.1 t -88.06 -21.43 7.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.06 98.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.048 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.13 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 18.0 t -80.73 -47.63 1.2 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 73.0 Cg_endo -76.88 -19.93 13.68 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.227 1.951 . . . . 0.0 112.656 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.78 -27.3 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.01 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.798 0.333 . . . . 0.0 111.288 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.49 6.6 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.68 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -108.64 -27.43 9.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.338 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.6 m -100.19 -28.65 12.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 2.1 p -72.2 -45.69 60.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.306 0.575 . . . . 0.0 110.65 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.61 -32.87 73.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.138 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.68 65.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.514 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.586 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.8 t -80.78 -47.9 1.17 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.644 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 84.4 Cg_endo -82.93 -44.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.419 2.079 . . . . 0.0 112.896 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 8.9 t -68.62 -11.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.814 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 6' ' ' LEU . . . -50.21 -27.45 5.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.597 0.236 . . . . 0.0 111.359 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.41 22.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -110.85 -33.68 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.382 . . . . 0.0 110.328 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 m -115.72 -21.02 9.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.223 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 11.0 t -94.68 -25.85 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 0.0 111.024 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.5 -26.35 60.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.449 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.32 33.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.959 -179.616 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.671 0.272 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.3 t -90.15 -51.3 0.34 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.081 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 73.2 Cg_endo -90.57 14.8 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.781 2.321 . . . . 0.0 112.611 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.21 -22.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.567 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.54 -41.99 31.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.251 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.28 19.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.474 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -113.58 -32.11 6.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.008 0.432 . . . . 0.0 110.012 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 m -117.08 -20.0 9.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 4.4 t -97.15 -28.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.964 0.411 . . . . 0.0 110.626 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.64 58.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.988 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.71 -21.91 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.471 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.752 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.414 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.565 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 21.0 t -60.23 -53.07 68.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.935 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 14.5 Cg_endo -57.35 -51.37 8.64 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.358 2.038 . . . . 0.0 112.76 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HB ' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t -73.78 -9.66 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.768 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -21.41 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.561 0.219 . . . . 0.0 111.43 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.4 tt -85.24 10.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.799 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.97 -30.63 8.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.285 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 m -98.04 -27.68 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.652 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 1.4 p -72.93 -44.35 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.21 0.528 . . . . 0.0 110.616 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -66.59 -32.88 74.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.05 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.856 -179.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.545 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.3 t -86.64 -47.16 0.53 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 35.8 Cg_exo -59.69 -29.83 90.69 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.222 1.948 . . . . 0.0 111.884 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -35.77 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.185 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.72 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 pt -87.74 23.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 111.691 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -115.32 -33.56 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 110.216 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -116.92 -16.25 10.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.225 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.7 t -103.79 -32.12 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.939 0.399 . . . . 0.0 110.817 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.18 72.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.41 -24.15 34.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.482 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.895 0.379 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 12.3 t -73.44 -48.19 7.17 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.449 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 91.9 Cg_endo -78.54 -22.95 8.91 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.276 1.984 . . . . 0.0 112.598 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.82 -14.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.59 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -56.28 -31.75 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.624 0.25 . . . . 0.0 111.279 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.39 12.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -105.98 -28.09 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.963 0.411 . . . . 0.0 110.257 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -114.69 -27.78 7.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 20.1 t -86.37 -26.35 6.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 111.002 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.38 75.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -31.31 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.644 -179.777 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -58.98 -48.83 96.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.824 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.5 -44.77 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.504 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.47 -2.84 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.654 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.02 25.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.572 0.225 . . . . 0.0 111.427 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.65 15.11 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -108.84 -33.89 6.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 110.016 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -106.72 -26.12 11.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.99 -20.27 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.0 -2.38 55.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.699 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.05 -63.36 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.358 . . . . 0.0 111.561 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.201 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.848 -179.685 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.852 0.358 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.2 t -72.55 -47.4 9.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.8 Cg_exo -70.68 -38.47 5.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.561 2.174 . . . . 0.0 112.236 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.69 -2.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.616 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -72.18 0.95 8.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 12.48 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 111.191 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -112.91 -34.15 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -117.96 -11.06 10.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 39.5 t -106.68 -17.29 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.829 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.62 -35.6 67.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.95 -40.47 31.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.424 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.889 0.376 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.61 107.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.28 105.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -110.9 98.16 37.12 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.09 -65.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.542 2.161 . . . . 0.0 112.444 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.97 32.55 1.38 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.9 t -77.83 -48.13 2.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.772 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 82.6 Cg_endo -78.01 -18.21 13.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.237 1.958 . . . . 0.0 112.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.9 t -99.17 -2.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.742 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.78 -22.75 25.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.656 0.265 . . . . 0.0 111.489 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.469 HD13 HG23 ' A' ' 11' ' ' ILE . 21.5 mt -87.08 12.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.727 0.299 . . . . 0.0 111.78 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -108.05 -29.05 9.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 110.268 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -109.99 -26.69 9.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -87.73 -29.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.22 73.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.28 85.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.247 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.31 -46.2 93.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.36 -37.08 78.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -98.6 38.88 1.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.3 -37.42 8.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.64 -58.54 8.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.027 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -62.88 -30.66 71.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.55 -47.24 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.211 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.1 mm -85.01 3.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.726 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -120.2 4.84 10.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.515 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.08 55.58 0.12 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.4 tttt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.033 179.831 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.861 0.362 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.45 42.3 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.56 92.85 8.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -170.35 86.64 0.54 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.13 58.82 5.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.661 2.241 . . . . 0.0 112.417 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.9 tp -163.48 31.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.6 t -77.26 -47.72 2.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.97 -2.68 12.89 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.249 1.966 . . . . 0.0 112.983 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -98.89 -35.69 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -28.95 14.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.17 17.39 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -106.96 -31.6 8.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.888 0.375 . . . . 0.0 110.436 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -117.73 -22.12 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.308 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.8 -23.97 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.59 85.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.362 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.1 90.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.63 -58.49 7.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.554 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.06 -34.04 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -100.73 49.29 0.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.07 -66.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -49.17 -59.55 3.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.702 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -59.71 -23.44 63.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.28 -46.59 40.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.3 mm -89.07 3.62 5.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.932 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -105.44 3.67 29.85 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.561 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -113.58 33.16 5.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.792 0.329 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 59.91 36.69 21.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.74 19.89 9.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -126.15 94.59 40.99 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.643 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.78 -46.0 2.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.433 2.088 . . . . 0.0 112.549 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.7 tp -168.12 33.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.923 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 t -59.08 -48.23 96.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.85 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 70.9 Cg_endo -75.76 -45.74 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.162 1.908 . . . . 0.0 112.755 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.8 -11.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.692 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 -34.78 63.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 111.372 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 13.8 mm -87.03 14.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.812 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.97 -30.73 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.403 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.3 m -114.71 -19.58 11.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.275 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 t -96.69 -23.99 4.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.854 0.359 . . . . 0.0 111.023 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.92 82.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.56 -18.31 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.64 -68.66 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.735 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.74 -37.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 111.653 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -104.14 64.34 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.916 0.389 . . . . 0.0 111.251 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.09 -44.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.85 -58.52 7.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -29.08 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.045 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.11 59.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.69 3.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -105.32 4.83 31.35 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.562 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -138.62 50.96 1.84 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.915 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.784 0.325 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -74.51 108.16 7.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -86.46 131.77 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -116.68 88.28 24.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.21 2.26 8.6 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 112.911 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.7 32.49 6.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.768 0.318 . . . . 0.0 111.048 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 39.6 t -73.62 -49.32 6.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.504 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 66.2 Cg_endo -74.03 -25.95 13.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.241 1.961 . . . . 0.0 112.322 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.97 -20.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.211 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.72 4.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 pt -87.01 15.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.43 -31.84 8.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.421 . . . . 0.0 110.096 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -109.89 -28.54 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.677 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 -27.8 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.3 67.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.45 76.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.301 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.47 -22.88 25.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.762 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 18' ' ' ILE . 6.7 mt -123.01 -36.28 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -110.27 68.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 111.275 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.8 -50.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.689 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -59.18 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -65.35 -28.95 69.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.43 22.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.8 mt -85.45 3.41 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.582 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -117.72 4.83 12.28 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.461 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 54.75 0.38 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.798 0.332 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 99.7 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -121.85 94.2 4.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -168.33 74.82 0.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.36 63.57 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.862 2.374 . . . . 0.0 112.298 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp -168.18 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.977 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.6 t -79.69 -48.16 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.7 Cg_exo -71.01 -28.9 18.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.637 2.225 . . . . 0.0 112.142 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.9 t -92.62 -6.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.699 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.88 -24.57 16.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 111.368 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.2 tt -85.03 10.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.12 -31.64 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 110.053 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.6 m -104.99 -28.06 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.7 t -88.4 -26.79 5.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.66 -32.88 47.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.15 -8.95 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.706 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.94 -76.28 0.99 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.713 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.2 mt -68.98 -29.05 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.623 0.249 . . . . 0.0 111.519 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -110.9 49.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.237 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.88 -61.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.29 -56.34 15.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.925 0.393 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.15 -23.05 63.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.249 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.56 -44.92 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.871 0.367 . . . . 0.0 111.282 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.3 mt -86.95 4.03 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.969 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.76 4.0 10.58 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.29 43.23 3.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.833 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.86 0.362 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 54.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 141.09 5.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.017 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 t90 51.97 68.19 3.41 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.027 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.94 61.23 3.82 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.63 33.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.727 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 t -64.46 -54.35 38.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.717 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 11.9 Cg_endo -55.58 -21.78 32.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.294 1.996 . . . . 0.0 112.751 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.6 -31.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.238 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -49.85 -35.17 22.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.67 20.41 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -108.26 -36.18 6.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.509 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 m -121.19 -12.73 8.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 2.8 t -104.96 -16.58 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.54 -31.6 60.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.91 -25.53 30.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.538 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.54 -74.74 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.927 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.9 mm -62.64 -34.59 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.662 0.268 . . . . 0.0 111.506 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -103.45 51.59 0.79 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.902 0.382 . . . . 0.0 111.187 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -146.59 -71.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.894 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.402 ' O ' ' CB ' ' A' ' 25' ' ' ARG . 2.8 t80 -58.38 -44.31 88.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.914 0.388 . . . . 0.0 110.529 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.89 -21.57 54.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.195 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.04 16.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.488 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mt -85.75 3.77 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 4.7 ttt85 -125.32 4.95 7.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.665 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.47 36.72 0.23 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.885 0.374 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.51 169.84 11.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.951 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.68 -166.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.81 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -111.17 83.24 3.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.28 4.84 6.67 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.736 2.291 . . . . 0.0 112.865 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.33 34.38 3.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t -77.03 -48.24 2.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.411 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 89.1 Cg_endo -81.85 -26.04 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.376 2.051 . . . . 0.0 112.519 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.0 -36.56 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.065 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -51.61 -36.36 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -83.71 10.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.588 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -107.41 -31.6 8.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.041 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.8 m -107.58 -27.13 10.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.676 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 15.0 t -91.22 -3.53 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.078 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.69 -38.31 5.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.2 63.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.381 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.52 -52.57 1.12 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.575 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.61 -34.06 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.546 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -121.57 72.72 1.02 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.182 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.76 -44.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -62.14 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.35 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.31 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.74 -47.03 15.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.919 0.39 . . . . 0.0 111.348 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.6 mm -87.07 3.9 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.189 0.519 . . . . 0.0 111.917 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -127.4 4.93 6.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.838 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.33 54.04 0.11 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.888 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.902 0.382 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.32 137.49 52.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -102.13 -53.92 2.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -76.01 118.76 73.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.591 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.11 -42.96 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.0 112.885 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.89 40.62 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.482 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 t -86.69 -48.61 0.5 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 62.8 Cg_endo -88.8 14.3 2.3 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.724 2.283 . . . . 0.0 112.897 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.99 -26.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.589 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.27 -36.29 30.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 mp -84.74 12.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.685 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -106.33 -31.56 8.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 110.15 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 m -110.34 -27.58 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.711 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 18.9 t -89.26 -26.31 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.65 -11.87 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.644 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.51 -31.75 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 111.519 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.67 -68.78 0.47 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.9 mm -56.21 -29.89 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.451 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -122.2 61.69 0.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -176.38 -57.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.26 -63.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 0.0 110.725 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -21.66 65.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.42 61.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.241 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.2 mt -99.81 3.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 0.0 111.98 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 3.92 49.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.654 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -112.2 33.69 4.72 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.87 0.367 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.46 103.46 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.81 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -79.39 87.0 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.408 ' CD1' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -169.2 131.98 1.15 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.755 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD2' ' CD1' ' A' ' 4' ' ' TRP . 73.7 Cg_endo -90.37 31.96 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.82 2.347 . . . . 0.0 112.801 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.87 31.19 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.039 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t -82.17 -48.84 0.9 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 98.1 Cg_endo -84.47 -26.46 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.076 . . . . 0.0 112.438 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.54 -29.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.68 -42.85 57.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.24 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.18 9.7 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.619 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.65 -29.75 8.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.224 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 m -113.36 -23.13 10.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 6.4 t -96.59 -25.8 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.7 74.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.84 -38.81 53.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.328 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.15 -27.41 57.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.576 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.1 mt -113.27 -30.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.697 0.284 . . . . 0.0 111.719 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.34 72.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -162.1 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.674 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.95 -54.14 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.98 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -62.34 -30.23 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.62 -45.95 60.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.197 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.2 mm -85.61 3.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.757 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.44 4.99 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.529 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -163.22 53.68 0.18 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.972 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 tptt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.802 0.334 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -108.25 95.97 6.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.38 -26.88 18.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.14 115.5 9.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.83 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.92 44.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.588 2.192 . . . . 0.0 112.712 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.24 32.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.757 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.545 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -66.92 -52.36 32.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.814 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 25.6 Cg_endo -62.06 -15.82 46.16 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.639 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.56 -28.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.62 -36.73 36.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.273 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 pt -84.7 12.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.779 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -107.95 -31.82 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.419 . . . . 0.0 110.105 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -109.94 -25.03 10.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.76 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 14.3 t -94.26 -28.44 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.954 0.407 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.54 -38.72 54.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 -19.69 59.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.16 -61.63 1.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.567 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 mm -67.84 -36.88 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.79 65.66 0.76 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.87 -40.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -69.71 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.792 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.41 -22.79 34.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.94 1.78 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.7 3.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.947 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -107.63 5.21 26.68 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.611 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.91 44.7 0.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.942 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.0 tttt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.762 0.315 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.38 134.26 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 62.41 86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -120.88 60.5 8.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.32 -77.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.712 2.275 . . . . 0.0 112.775 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.97 46.59 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 4.8 t -83.41 -45.01 0.83 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.622 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 25.8 Cg_exo -62.56 -39.87 41.89 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.537 2.158 . . . . 0.0 112.57 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.64 -5.46 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.816 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.09 -21.21 45.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.251 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.4 mp -89.33 13.46 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.751 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -108.86 -28.94 8.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.549 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -106.16 -25.72 11.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -82.08 -40.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.154 0.502 . . . . 0.0 110.557 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.46 -29.85 70.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.12 -27.15 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.06 -70.37 0.81 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.611 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.3 mm -58.64 -42.74 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.271 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.5 60.94 2.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.978 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.09 -46.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.841 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.71 -57.38 13.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.868 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -65.01 -28.75 69.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.4 66.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 27.2 mm -86.88 4.06 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.731 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.52 4.53 9.6 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 36.83 1.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.766 0.317 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -114.07 119.93 38.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -164.86 158.38 17.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.06 86.94 50.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.52 52.26 4.26 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.207 2.605 . . . . 0.0 112.352 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -171.29 32.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.1 t -85.2 -46.55 0.64 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.447 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 16.7 Cg_exo -67.5 -25.33 41.38 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.511 2.14 . . . . 0.0 112.38 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.93 -45.7 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.27 -47.4 36.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.244 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.06 12.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.632 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.42 -31.53 9.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.153 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -117.57 -24.76 7.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.224 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 13.1 t -88.06 -21.43 7.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.06 98.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.048 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.13 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.92 -49.62 8.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.97 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.37 . . . . 0.0 111.22 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -90.65 59.47 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.102 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.25 -43.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.34 -55.42 35.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -60.15 -31.48 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.94 -44.63 63.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 22.2 mt -86.48 3.3 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.718 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -128.89 5.46 5.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.551 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -156.87 37.13 0.3 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.809 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -139.88 166.35 24.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.64 112.98 16.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -148.46 73.14 10.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.12 62.42 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.827 2.351 . . . . 0.0 112.438 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.35 30.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.77 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 18.0 t -80.73 -47.63 1.2 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 73.0 Cg_endo -76.88 -19.93 13.68 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.227 1.951 . . . . 0.0 112.656 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.78 -27.3 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.01 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.798 0.333 . . . . 0.0 111.288 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.49 6.6 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.68 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -108.64 -27.43 9.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.338 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.6 m -100.19 -28.65 12.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 2.1 p -72.2 -45.69 60.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.306 0.575 . . . . 0.0 110.65 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.61 -32.87 73.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.138 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.68 65.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.514 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 -52.19 1.31 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.586 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -69.5 -33.4 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.319 . . . . 0.0 111.314 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -111.29 59.43 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.76 -78.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 2.0 t80 -54.34 -43.75 71.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.849 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -84.62 -13.24 52.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.36 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.26 -45.49 11.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.959 0.409 . . . . 0.0 111.54 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 30.3 mt -86.33 3.66 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.176 0.512 . . . . 0.0 112.126 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 4.99 22.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.531 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -145.09 40.15 1.23 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.852 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.889 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -117.91 115.2 24.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.41 127.63 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.37 82.21 14.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.781 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -87.56 -73.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.806 2.337 . . . . 0.0 112.879 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -133.09 51.4 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 0.0 110.812 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.8 t -80.78 -47.9 1.17 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.644 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 84.4 Cg_endo -82.93 -44.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.419 2.079 . . . . 0.0 112.896 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 8.9 t -68.62 -11.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.814 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 6' ' ' LEU . . . -50.21 -27.45 5.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.597 0.236 . . . . 0.0 111.359 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.2 tt -91.41 22.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.411 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -110.85 -33.68 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.382 . . . . 0.0 110.328 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 m -115.72 -21.02 9.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.223 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 11.0 t -94.68 -25.85 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 0.0 111.024 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.5 -26.35 60.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.449 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.32 33.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.66 -77.13 1.05 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.959 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -56.63 -32.05 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -103.27 64.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.185 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.22 -51.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -55.25 -60.41 3.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.776 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.89 -26.41 67.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.996 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.2 61.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.282 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.0 mt -87.18 3.48 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.908 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -99.63 3.58 45.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.68 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -102.04 31.28 4.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.003 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.877 0.37 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -87.11 166.89 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.38 -57.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.05 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -43.13 99.26 0.21 Allowed Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.428 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -93.57 39.03 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.132 2.555 . . . . 0.0 112.743 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.97 28.86 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.24 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.3 t -90.15 -51.3 0.34 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.081 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 73.2 Cg_endo -90.57 14.8 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.781 2.321 . . . . 0.0 112.611 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.21 -22.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.567 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.54 -41.99 31.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.251 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.28 19.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.474 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -113.58 -32.11 6.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.008 0.432 . . . . 0.0 110.012 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 m -117.08 -20.0 9.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 4.4 t -97.15 -28.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.964 0.411 . . . . 0.0 110.626 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.58 -33.64 58.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.988 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.71 -21.91 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.471 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.89 -51.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.752 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.26 -43.41 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.0 111.679 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.76 71.22 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.312 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 175.87 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -56.56 -60.62 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -58.42 -27.24 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.73 -46.89 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.7 mt -85.31 3.4 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.895 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -108.46 4.49 24.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.697 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 37.96 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.802 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.742 0.306 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.24 99.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 1.8 p90 -134.0 -51.11 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.538 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 1.4 m95 -104.44 170.28 6.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 4' ' ' TRP . 2.7 Cg_endo -42.25 -75.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.304 2.669 . . . . 0.0 112.573 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.414 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -165.53 38.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.565 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 21.0 t -60.23 -53.07 68.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.935 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 14.5 Cg_endo -57.35 -51.37 8.64 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.358 2.038 . . . . 0.0 112.76 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' HB ' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t -73.78 -9.66 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.768 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -21.41 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.561 0.219 . . . . 0.0 111.43 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 10.4 tt -85.24 10.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.799 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.97 -30.63 8.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.285 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 m -98.04 -27.68 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.652 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 1.4 p -72.93 -44.35 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.21 0.528 . . . . 0.0 110.616 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -66.59 -32.88 74.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.05 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.82 -71.93 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.856 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 18' ' ' ILE . 35.9 mt -61.3 -39.23 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -97.3 40.35 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.56 -57.3 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -54.27 -55.38 28.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.787 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -59.1 -27.02 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.62 -49.47 53.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.885 0.374 . . . . 0.0 110.977 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 23.3 mt -86.52 3.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.751 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 5.2 41.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.601 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 43.44 0.31 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.937 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.842 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 133.07 38.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -163.17 -79.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.777 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.429 ' CE3' ' HB ' ' A' ' 7' ' ' VAL . 7.8 m0 -112.56 136.71 21.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.722 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.58 -86.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.029 . . . . 0.0 112.303 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.46 43.23 3.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.545 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.3 t -86.64 -47.16 0.53 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 35.8 Cg_exo -59.69 -29.83 90.69 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.222 1.948 . . . . 0.0 111.884 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -75.21 -35.77 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.185 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.72 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.6 pt -87.74 23.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 111.691 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -115.32 -33.56 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 110.216 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -116.92 -16.25 10.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.225 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.7 t -103.79 -32.12 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.939 0.399 . . . . 0.0 110.817 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.73 -35.18 72.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.037 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.41 -24.15 34.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.73 -67.33 0.85 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 mm -63.86 -40.18 88.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.914 0.387 . . . . 0.0 111.189 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.68 57.55 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.986 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.404 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -175.38 -52.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -57.25 -54.12 50.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -66.61 -29.6 69.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.93 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 24' ' ' ILE . 28.2 mt -87.09 3.97 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.798 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.61 4.91 10.6 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.477 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.06 42.51 1.31 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.808 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.92 179.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.0 tttm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.804 0.335 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -130.97 127.73 38.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.776 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.07 -50.42 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.543 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 2.2 m95 -79.91 169.75 18.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.991 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 4' ' ' TRP . 1.1 Cg_endo -40.98 -72.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.412 2.742 . . . . 0.0 112.521 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -164.37 34.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.469 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 12.3 t -73.44 -48.19 7.17 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.449 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 91.9 Cg_endo -78.54 -22.95 8.91 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.276 1.984 . . . . 0.0 112.598 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.82 -14.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.59 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -56.28 -31.75 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.624 0.25 . . . . 0.0 111.279 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.39 12.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -105.98 -28.09 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.963 0.411 . . . . 0.0 110.257 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -114.69 -27.78 7.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 20.1 t -86.37 -26.35 6.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 111.002 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.38 75.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -31.31 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.25 -66.58 1.25 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.644 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mt -66.58 -54.76 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -84.74 57.01 4.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.11 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.79 -64.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -49.03 -64.03 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.709 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.71 -18.53 60.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.5 -52.46 10.62 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.964 0.412 . . . . 0.0 111.416 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mt -86.65 3.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.044 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 5.2 tpm_? -105.73 4.52 30.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -137.22 46.22 2.17 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.941 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.813 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 tttp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -106.35 -168.16 1.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 t80 62.44 74.07 0.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -49.84 102.21 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.463 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.94 -66.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.747 2.298 . . . . 0.0 112.281 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -141.9 32.72 1.58 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.864 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -58.98 -48.83 96.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.824 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.5 -44.77 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.504 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.47 -2.84 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.654 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.02 25.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.572 0.225 . . . . 0.0 111.427 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.7 mp -86.65 15.11 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.703 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -108.84 -33.89 6.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 110.016 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -106.72 -26.12 11.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.8 t -90.99 -20.27 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 19' ' ' ASN . . . -93.0 -2.38 55.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.699 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.05 -63.36 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.358 . . . . 0.0 111.561 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.67 -61.45 0.91 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.848 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.4 mp -46.14 -37.76 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.407 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . 11.8 t-20 -96.33 30.63 2.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.68 -63.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.599 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -57.97 -49.05 78.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.343 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -67.33 -26.94 66.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.77 66.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.017 0.437 . . . . 0.0 110.877 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.7 mt -87.18 3.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.811 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.95 4.69 13.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.572 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.98 37.26 0.95 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.824 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.877 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.766 0.317 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -102.8 -178.58 3.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 -34.73 9.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.771 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -156.6 68.79 4.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.39 64.1 4.49 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.583 2.189 . . . . 0.0 112.117 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.92 36.51 0.3 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.2 t -72.55 -47.4 9.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.8 Cg_exo -70.68 -38.47 5.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.561 2.174 . . . . 0.0 112.236 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.69 -2.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.616 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -72.18 0.95 8.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.34 12.48 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 111.191 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -112.91 -34.15 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -117.96 -11.06 10.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 39.5 t -106.68 -17.29 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.829 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.62 -35.6 67.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.95 -40.47 31.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.06 73.01 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.424 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 18' ' ' ILE . 28.8 mt -95.59 -35.28 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 120.744 0.307 . . . . 0.0 111.556 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -117.49 60.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.17 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.35 -58.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.67 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.78 -19.06 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.97 26.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.536 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.1 mm -120.69 4.54 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.103 0.477 . . . . 0.0 111.938 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.2 4.4 9.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.576 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 35.74 0.78 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.03 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.98 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.49 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.9 t -77.83 -48.13 2.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.772 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 82.6 Cg_endo -78.01 -18.21 13.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.237 1.958 . . . . 0.0 112.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' A' ' 6' ' ' LEU . 16.9 t -99.17 -2.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -55.78 -22.75 25.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.656 0.265 . . . . 0.0 111.489 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 11' ' ' ILE . 21.5 mt -87.08 12.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.727 0.299 . . . . 0.0 111.78 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -108.05 -29.05 9.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 110.268 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -109.99 -26.69 9.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' ALA . 25.7 t -87.73 -29.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.22 73.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.28 85.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.247 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.422 -180.0 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 9' ' ' VAL . 7.9 tp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.5 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.6 t -77.26 -47.72 2.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.97 -2.68 12.89 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.249 1.966 . . . . 0.0 112.983 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 6' ' ' LEU . 1.9 t -98.89 -35.69 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -28.95 14.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.2 mt -90.17 17.39 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -106.96 -31.6 8.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.888 0.375 . . . . 0.0 110.436 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -117.73 -22.12 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.308 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.8 -23.97 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -66.91 -42.59 85.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.1 90.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.554 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 tp . . . . . 0 N--CA 1.459 -0.021 0 CA-C-O 120.779 0.323 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.5 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 t -59.08 -48.23 96.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.85 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 70.9 Cg_endo -75.76 -45.74 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.162 1.908 . . . . 0.0 112.755 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.8 -11.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.692 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -54.87 -34.78 63.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 11' ' ' ILE . 13.8 mm -87.03 14.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.812 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.97 -30.73 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.403 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.3 m -114.71 -19.58 11.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.275 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 10' ' ' ALA . 7.7 t -96.69 -23.99 4.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.854 0.359 . . . . 0.0 111.023 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.92 82.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.56 -18.31 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.735 -179.735 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.768 0.318 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 39.6 t -73.62 -49.32 6.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.504 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 66.2 Cg_endo -74.03 -25.95 13.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.241 1.961 . . . . 0.0 112.322 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.97 -20.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.211 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.72 4.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.2 pt -87.01 15.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.43 -31.84 8.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.421 . . . . 0.0 110.096 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -109.89 -28.54 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.677 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 -27.8 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -72.65 -35.3 67.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.45 76.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.301 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.762 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.6 t -79.69 -48.16 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.7 Cg_exo -71.01 -28.9 18.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.637 2.225 . . . . 0.0 112.142 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.9 t -92.62 -6.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.699 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.88 -24.57 16.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 111.368 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.2 tt -85.03 10.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.676 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.12 -31.64 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 110.053 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.6 m -104.99 -28.06 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 10' ' ' ALA . 31.7 t -88.4 -26.79 5.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -78.66 -32.88 47.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.15 -8.95 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.706 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.349 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.713 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.933 0.397 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 t -64.46 -54.35 38.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.717 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 11.9 Cg_endo -55.58 -21.78 32.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.294 1.996 . . . . 0.0 112.751 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.6 -31.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.238 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -49.85 -35.17 22.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 mp -91.67 20.41 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -108.26 -36.18 6.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.509 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 m -121.19 -12.73 8.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 2.8 t -104.96 -16.58 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -75.54 -31.6 60.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.91 -25.53 30.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.538 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.927 -179.657 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t -77.03 -48.24 2.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.411 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 89.1 Cg_endo -81.85 -26.04 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.376 2.051 . . . . 0.0 112.519 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.0 -36.56 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.065 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -51.61 -36.36 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -83.71 10.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.588 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -107.41 -31.6 8.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.041 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.8 m -107.58 -27.13 10.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.676 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' ALA . 15.0 t -91.22 -3.53 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.078 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.69 -38.31 5.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.2 63.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.381 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.575 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 t -86.69 -48.61 0.5 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 62.8 Cg_endo -88.8 14.3 2.3 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.724 2.283 . . . . 0.0 112.897 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.99 -26.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.589 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.27 -36.29 30.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.6 mp -84.74 12.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -106.33 -31.56 8.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 110.15 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 m -110.34 -27.58 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.711 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 18.9 t -89.26 -26.31 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -79.65 -11.87 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.644 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.51 -31.75 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 111.519 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.805 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t -82.17 -48.84 0.9 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 98.1 Cg_endo -84.47 -26.46 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.076 . . . . 0.0 112.438 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.54 -29.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -50.68 -42.85 57.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.24 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 2.1 mp -84.18 9.7 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.619 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.65 -29.75 8.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.224 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 m -113.36 -23.13 10.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 10' ' ' ALA . 6.4 t -96.59 -25.8 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.7 74.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.84 -38.81 53.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.328 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.576 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -66.92 -52.36 32.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.814 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 25.6 Cg_endo -62.06 -15.82 46.16 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.639 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.56 -28.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.62 -36.73 36.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.273 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 pt -84.7 12.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.779 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -107.95 -31.82 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.419 . . . . 0.0 110.105 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -109.94 -25.03 10.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.76 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 14.3 t -94.26 -28.44 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.954 0.407 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -76.54 -38.72 54.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 -19.69 59.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.567 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 4.8 t -83.41 -45.01 0.83 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.622 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 25.8 Cg_exo -62.56 -39.87 41.89 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.537 2.158 . . . . 0.0 112.57 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.64 -5.46 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.816 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -58.09 -21.21 45.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.251 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.4 mp -89.33 13.46 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -108.86 -28.94 8.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.549 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -106.16 -25.72 11.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -82.08 -40.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.154 0.502 . . . . 0.0 110.557 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.46 -29.85 70.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.12 -27.15 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.611 -179.822 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.1 t -85.2 -46.55 0.64 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.447 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 16.7 Cg_exo -67.5 -25.33 41.38 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.511 2.14 . . . . 0.0 112.38 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.93 -45.7 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -48.27 -47.4 36.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.244 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -83.06 12.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.632 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.42 -31.53 9.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.153 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -117.57 -24.76 7.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.224 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 10' ' ' ALA . 13.1 t -88.06 -21.43 7.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -60.8 -43.06 98.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.13 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 18.0 t -80.73 -47.63 1.2 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 73.0 Cg_endo -76.88 -19.93 13.68 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.227 1.951 . . . . 0.0 112.656 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.78 -27.3 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.01 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.798 0.333 . . . . 0.0 111.288 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.3 mt -85.49 6.6 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.68 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -108.64 -27.43 9.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.338 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.6 m -100.19 -28.65 12.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 2.1 p -72.2 -45.69 60.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.306 0.575 . . . . 0.0 110.65 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.61 -32.87 73.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.138 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.68 65.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.514 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.586 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.8 t -80.78 -47.9 1.17 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.644 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 84.4 Cg_endo -82.93 -44.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.419 2.079 . . . . 0.0 112.896 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 8.9 t -68.62 -11.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.814 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 6' ' ' LEU . . . -50.21 -27.45 5.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.597 0.236 . . . . 0.0 111.359 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 15' ' ' ALA . 16.2 tt -91.41 22.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.411 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 9' ' ' VAL . 18.4 t-20 -110.85 -33.68 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.382 . . . . 0.0 110.328 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 m -115.72 -21.02 9.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.223 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 11.0 t -94.68 -25.85 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 0.0 111.024 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -73.5 -26.35 60.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.449 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.32 33.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.959 -179.616 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.671 0.272 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.3 t -90.15 -51.3 0.34 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.081 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 73.2 Cg_endo -90.57 14.8 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.781 2.321 . . . . 0.0 112.611 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.21 -22.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.567 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.54 -41.99 31.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.251 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -88.28 19.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.474 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -113.58 -32.11 6.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.008 0.432 . . . . 0.0 110.012 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 m -117.08 -20.0 9.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 4.4 t -97.15 -28.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.964 0.411 . . . . 0.0 110.626 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 11' ' ' ILE . . . -76.58 -33.64 58.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.988 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.71 -21.91 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.471 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.752 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.577 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 21.0 t -60.23 -53.07 68.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.935 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 14.5 Cg_endo -57.35 -51.37 8.64 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.358 2.038 . . . . 0.0 112.76 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' HB ' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t -73.78 -9.66 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.768 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -21.41 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.561 0.219 . . . . 0.0 111.43 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 14' ' ' VAL . 10.4 tt -85.24 10.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.799 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.97 -30.63 8.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.285 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 m -98.04 -27.68 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.652 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 1.4 p -72.93 -44.35 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.21 0.528 . . . . 0.0 110.616 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -66.59 -32.88 74.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.05 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.856 -179.777 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.545 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.3 t -86.64 -47.16 0.53 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 35.8 Cg_exo -59.69 -29.83 90.69 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.222 1.948 . . . . 0.0 111.884 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -75.21 -35.77 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.72 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . 3.6 pt -87.74 23.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 111.691 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -115.32 -33.56 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 110.216 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -116.92 -16.25 10.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.225 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.7 t -103.79 -32.12 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.939 0.399 . . . . 0.0 110.817 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . . . -70.73 -35.18 72.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.037 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.41 -24.15 34.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.482 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.895 0.379 . . . . 0.0 111.087 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 12.3 t -73.44 -48.19 7.17 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.449 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 91.9 Cg_endo -78.54 -22.95 8.91 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.276 1.984 . . . . 0.0 112.598 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.82 -14.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.59 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -56.28 -31.75 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.624 0.25 . . . . 0.0 111.279 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.39 12.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -105.98 -28.09 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.963 0.411 . . . . 0.0 110.257 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -114.69 -27.78 7.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 10' ' ' ALA . 20.1 t -86.37 -26.35 6.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 111.002 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.38 75.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -31.31 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.644 -179.777 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 4.4 tp . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -58.98 -48.83 96.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.824 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.5 -44.77 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.504 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 9' ' ' VAL . 21.8 t -80.47 -2.84 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.654 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -53.68 -27.02 25.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.572 0.225 . . . . 0.0 111.427 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mp -86.65 15.11 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.703 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' HB3' HG12 ' A' ' 9' ' ' VAL . 17.5 t-20 -108.84 -33.89 6.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -106.72 -26.12 11.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 10' ' ' ALA . 15.8 t -90.99 -20.27 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -93.0 -2.38 55.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.699 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.05 -63.36 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.358 . . . . 0.0 111.561 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.201 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.848 -179.685 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.852 0.358 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.2 t -72.55 -47.4 9.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.8 Cg_exo -70.68 -38.47 5.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.561 2.174 . . . . 0.0 112.236 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.69 -2.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.616 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -72.18 0.95 8.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.34 12.48 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 111.191 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -112.91 -34.15 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -117.96 -11.06 10.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 39.5 t -106.68 -17.29 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.829 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -72.62 -35.6 67.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.95 -40.47 31.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.424 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.889 0.376 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.61 107.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.28 105.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -110.9 98.16 37.12 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.09 -65.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.542 2.161 . . . . 0.0 112.444 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -142.97 32.55 1.38 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.49 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.9 t -77.83 -48.13 2.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.772 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 82.6 Cg_endo -78.01 -18.21 13.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.237 1.958 . . . . 0.0 112.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' A' ' 6' ' ' LEU . 16.9 t -99.17 -2.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -55.78 -22.75 25.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.656 0.265 . . . . 0.0 111.489 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 11' ' ' ILE . 21.5 mt -87.08 12.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.727 0.299 . . . . 0.0 111.78 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -108.05 -29.05 9.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 110.268 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -109.99 -26.69 9.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' ALA . 25.7 t -87.73 -29.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.22 73.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.28 85.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.247 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.31 -46.2 93.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.36 -37.08 78.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -98.6 38.88 1.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -102.3 -37.42 8.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.64 -58.54 8.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.027 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -62.88 -30.66 71.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.55 -47.24 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.211 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 24' ' ' ILE . 25.1 mm -85.01 3.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.726 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -120.2 4.84 10.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.515 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.08 55.58 0.12 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.4 tttt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.033 179.831 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.861 0.362 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.45 42.3 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.56 92.85 8.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -170.35 86.64 0.54 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.13 58.82 5.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.661 2.241 . . . . 0.0 112.417 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 9' ' ' VAL . 7.9 tp -163.48 31.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.5 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.6 t -77.26 -47.72 2.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.97 -2.68 12.89 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.249 1.966 . . . . 0.0 112.983 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 6' ' ' LEU . 1.9 t -98.89 -35.69 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -28.95 14.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.2 mt -90.17 17.39 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -106.96 -31.6 8.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.888 0.375 . . . . 0.0 110.436 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -117.73 -22.12 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.308 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.8 -23.97 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -66.91 -42.59 85.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.617 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -65.93 -42.1 90.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.264 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.63 -58.49 7.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.554 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.06 -34.04 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -100.73 49.29 0.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.07 -66.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 2.4 t80 -49.17 -59.55 3.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.702 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -59.71 -23.44 63.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 20' ' ' LEU . . . -74.28 -46.59 40.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' ILE . 28.3 mm -89.07 3.62 5.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.932 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 13.1 ttp85 -105.44 3.67 29.85 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.561 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -113.58 33.16 5.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.792 0.329 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 59.91 36.69 21.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.74 19.89 9.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.535 ' CD1' HG21 ' A' ' 7' ' ' VAL . 4.0 m0 -126.15 94.59 40.99 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.643 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.78 -46.0 2.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.433 2.088 . . . . 0.0 112.549 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 tp -168.12 33.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 4' ' ' TRP . 19.9 t -59.08 -48.23 96.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.85 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 70.9 Cg_endo -75.76 -45.74 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.162 1.908 . . . . 0.0 112.755 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.8 -11.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.692 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -54.87 -34.78 63.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 11' ' ' ILE . 13.8 mm -87.03 14.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.812 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.97 -30.73 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.403 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.3 m -114.71 -19.58 11.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.275 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 18' ' ' ILE . 7.7 t -96.69 -23.99 4.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.854 0.359 . . . . 0.0 111.023 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.92 82.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.56 -18.31 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.64 -68.66 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.735 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.535 HD12 ' CG1' ' A' ' 14' ' ' VAL . 25.6 mt -70.74 -37.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 111.653 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -104.14 64.34 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.916 0.389 . . . . 0.0 111.251 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.09 -44.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.85 -58.52 7.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -29.08 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.045 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.11 59.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 24' ' ' ILE . 27.9 mt -86.69 3.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -105.32 4.83 31.35 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.562 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -138.62 50.96 1.84 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.915 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.784 0.325 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -74.51 108.16 7.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -86.46 131.77 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.792 ' O ' HG23 ' A' ' 7' ' ' VAL . 1.8 t90 -116.68 88.28 24.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.21 2.26 8.6 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 112.911 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.7 32.49 6.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.768 0.318 . . . . 0.0 111.048 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 4' ' ' TRP . 39.6 t -73.62 -49.32 6.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.504 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 66.2 Cg_endo -74.03 -25.95 13.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.241 1.961 . . . . 0.0 112.322 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.97 -20.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.211 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.72 4.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.2 pt -87.01 15.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.43 -31.84 8.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.421 . . . . 0.0 110.096 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -109.89 -28.54 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.677 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 -27.8 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -72.65 -35.3 67.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.45 76.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.301 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.47 -22.88 25.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.762 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mt -123.01 -36.28 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -110.27 68.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 111.275 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -152.8 -50.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.689 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -59.18 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -65.35 -28.95 69.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.43 22.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 24' ' ' ILE . 4.8 mt -85.45 3.41 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -117.72 4.83 12.28 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.461 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 54.75 0.38 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.798 0.332 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 99.7 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -121.85 94.2 4.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -168.33 74.82 0.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.36 63.57 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.862 2.374 . . . . 0.0 112.298 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp -168.18 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.977 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.6 t -79.69 -48.16 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.7 Cg_exo -71.01 -28.9 18.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.637 2.225 . . . . 0.0 112.142 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.9 t -92.62 -6.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.699 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.88 -24.57 16.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 111.368 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.2 tt -85.03 10.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.676 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.12 -31.64 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 110.053 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.6 m -104.99 -28.06 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 10' ' ' ALA . 31.7 t -88.4 -26.79 5.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -78.66 -32.88 47.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.15 -8.95 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.706 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.94 -76.28 0.99 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.713 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.2 mt -68.98 -29.05 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.623 0.249 . . . . 0.0 111.519 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -110.9 49.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.237 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.88 -61.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.29 -56.34 15.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.925 0.393 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.15 -23.05 63.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.249 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.56 -44.92 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.871 0.367 . . . . 0.0 111.282 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 24' ' ' ILE . 30.3 mt -86.95 4.03 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.969 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.76 4.0 10.58 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.29 43.23 3.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.833 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.86 0.362 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 54.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 141.09 5.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.017 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 t90 51.97 68.19 3.41 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.027 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.94 61.23 3.82 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.63 33.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.727 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 t -64.46 -54.35 38.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.717 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 11.9 Cg_endo -55.58 -21.78 32.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.294 1.996 . . . . 0.0 112.751 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.6 -31.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.238 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -49.85 -35.17 22.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 mp -91.67 20.41 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -108.26 -36.18 6.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.509 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 m -121.19 -12.73 8.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 18' ' ' ILE . 2.8 t -104.96 -16.58 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -75.54 -31.6 60.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.91 -25.53 30.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.538 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.54 -74.74 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.927 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.519 ' HB ' HG12 ' A' ' 14' ' ' VAL . 39.9 mm -62.64 -34.59 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.662 0.268 . . . . 0.0 111.506 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -103.45 51.59 0.79 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.902 0.382 . . . . 0.0 111.187 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' C ' HD13 ' A' ' 20' ' ' LEU . 2.8 tm? -146.59 -71.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.894 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.402 ' O ' ' CB ' ' A' ' 25' ' ' ARG . 2.8 t80 -58.38 -44.31 88.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.914 0.388 . . . . 0.0 110.529 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.89 -21.57 54.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.195 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.04 16.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.488 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.2 mt -85.75 3.77 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 4.7 ttt85 -125.32 4.95 7.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.665 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.47 36.72 0.23 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.885 0.374 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.51 169.84 11.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.951 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.68 -166.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.81 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 7' ' ' VAL . 6.0 t90 -111.17 83.24 3.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.28 4.84 6.67 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.736 2.291 . . . . 0.0 112.865 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -108.33 34.38 3.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 4' ' ' TRP . 8.5 t -77.03 -48.24 2.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.411 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 89.1 Cg_endo -81.85 -26.04 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.376 2.051 . . . . 0.0 112.519 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.0 -36.56 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.065 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -51.61 -36.36 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -83.71 10.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.588 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -107.41 -31.6 8.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.041 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.8 m -107.58 -27.13 10.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.676 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' ALA . 15.0 t -91.22 -3.53 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.078 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.69 -38.31 5.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.2 63.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.381 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.52 -52.57 1.12 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.575 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.61 -34.06 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.546 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -121.57 72.72 1.02 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.182 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.76 -44.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -62.14 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.35 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.31 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.74 -47.03 15.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.919 0.39 . . . . 0.0 111.348 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 24' ' ' ILE . 23.6 mm -87.07 3.9 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.189 0.519 . . . . 0.0 111.917 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -127.4 4.93 6.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.838 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.33 54.04 0.11 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.888 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.902 0.382 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.32 137.49 52.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -102.13 -53.92 2.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.401 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 22.5 m0 -76.01 118.76 73.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.591 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.11 -42.96 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.0 112.885 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.89 40.62 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 t -86.69 -48.61 0.5 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 62.8 Cg_endo -88.8 14.3 2.3 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.724 2.283 . . . . 0.0 112.897 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.99 -26.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.589 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.27 -36.29 30.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.6 mp -84.74 12.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -106.33 -31.56 8.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 110.15 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 m -110.34 -27.58 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.711 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 18.9 t -89.26 -26.31 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -79.65 -11.87 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.644 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.51 -31.75 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 111.519 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.67 -68.78 0.47 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.9 mm -56.21 -29.89 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.451 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -122.2 61.69 0.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD23 HD12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -176.38 -57.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.26 -63.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 0.0 110.725 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -21.66 65.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.42 61.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.241 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 24' ' ' ILE . 29.2 mt -99.81 3.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 0.0 111.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 3.92 49.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.654 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -112.2 33.69 4.72 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.87 0.367 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.46 103.46 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.81 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -79.39 87.0 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.439 ' CD1' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -169.2 131.98 1.15 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.755 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 4' ' ' TRP . 73.7 Cg_endo -90.37 31.96 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.82 2.347 . . . . 0.0 112.801 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.87 31.19 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.039 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t -82.17 -48.84 0.9 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 98.1 Cg_endo -84.47 -26.46 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.076 . . . . 0.0 112.438 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.54 -29.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -50.68 -42.85 57.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.24 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 2.1 mp -84.18 9.7 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.619 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.65 -29.75 8.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.224 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 m -113.36 -23.13 10.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 10' ' ' ALA . 6.4 t -96.59 -25.8 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.7 74.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 20' ' ' LEU . . . -76.84 -38.81 53.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.328 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.15 -27.41 57.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.576 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.1 mt -113.27 -30.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.697 0.284 . . . . 0.0 111.719 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.34 72.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD22 ' HB1' ' A' ' 16' ' ' ALA . 2.6 tp -162.1 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.95 -54.14 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.98 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -62.34 -30.23 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.62 -45.95 60.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.197 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 24' ' ' ILE . 30.2 mm -85.61 3.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.757 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.44 4.99 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.529 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -163.22 53.68 0.18 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.972 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 tptt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.802 0.334 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -108.25 95.97 6.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.38 -26.88 18.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.459 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -56.14 115.5 9.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.83 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.92 44.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.588 2.192 . . . . 0.0 112.712 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.24 32.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.757 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -66.92 -52.36 32.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.814 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 25.6 Cg_endo -62.06 -15.82 46.16 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.639 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.56 -28.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.62 -36.73 36.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.273 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 pt -84.7 12.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.779 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -107.95 -31.82 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.419 . . . . 0.0 110.105 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -109.94 -25.03 10.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.76 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 14.3 t -94.26 -28.44 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.954 0.407 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -76.54 -38.72 54.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 -19.69 59.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.16 -61.63 1.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.567 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 mm -67.84 -36.88 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.79 65.66 0.76 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.87 -40.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -69.71 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.792 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.41 -22.79 34.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.94 1.78 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 24' ' ' ILE . 25.4 mm -85.7 3.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.947 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -107.63 5.21 26.68 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.611 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.91 44.7 0.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.942 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.0 tttt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.762 0.315 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.38 134.26 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 62.41 86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -120.88 60.5 8.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.32 -77.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.712 2.275 . . . . 0.0 112.775 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -123.97 46.59 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 4.8 t -83.41 -45.01 0.83 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.622 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 25.8 Cg_exo -62.56 -39.87 41.89 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.537 2.158 . . . . 0.0 112.57 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.64 -5.46 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.816 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -58.09 -21.21 45.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.251 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.4 mp -89.33 13.46 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -108.86 -28.94 8.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.549 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -106.16 -25.72 11.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.08 -40.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.154 0.502 . . . . 0.0 110.557 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.46 -29.85 70.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' O ' HD13 ' A' ' 20' ' ' LEU . . . -83.12 -27.15 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.06 -70.37 0.81 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.611 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 14' ' ' VAL . 39.3 mm -58.64 -42.74 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.271 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.5 60.94 2.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.978 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -165.09 -46.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.841 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.71 -57.38 13.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.868 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -65.01 -28.75 69.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.4 66.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 24' ' ' ILE . 27.2 mm -86.88 4.06 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.731 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.52 4.53 9.6 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 36.83 1.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.766 0.317 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -114.07 119.93 38.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -164.86 158.38 17.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.06 86.94 50.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.52 52.26 4.26 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.207 2.605 . . . . 0.0 112.352 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -171.29 32.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 4' ' ' TRP . 3.1 t -85.2 -46.55 0.64 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.447 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 16.7 Cg_exo -67.5 -25.33 41.38 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.511 2.14 . . . . 0.0 112.38 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.93 -45.7 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -48.27 -47.4 36.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.244 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -83.06 12.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.632 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.42 -31.53 9.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.153 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -117.57 -24.76 7.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.224 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.51 HG12 ' CD1' ' A' ' 18' ' ' ILE . 13.1 t -88.06 -21.43 7.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -60.8 -43.06 98.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.584 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -65.76 -33.13 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.101 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.92 -49.62 8.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CD1' HG12 ' A' ' 14' ' ' VAL . 60.1 mt -63.97 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.37 . . . . 0.0 111.22 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -90.65 59.47 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.102 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -174.25 -43.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.34 -55.42 35.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -60.15 -31.48 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.94 -44.63 63.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 24' ' ' ILE . 22.2 mt -86.48 3.3 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.718 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -128.89 5.46 5.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.551 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -156.87 37.13 0.3 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.809 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -139.88 166.35 24.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.64 112.98 16.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -148.46 73.14 10.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.12 62.42 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.827 2.351 . . . . 0.0 112.438 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.35 30.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.77 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 18.0 t -80.73 -47.63 1.2 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 73.0 Cg_endo -76.88 -19.93 13.68 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.227 1.951 . . . . 0.0 112.656 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.78 -27.3 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.01 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.798 0.333 . . . . 0.0 111.288 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.3 mt -85.49 6.6 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.68 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -108.64 -27.43 9.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.338 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.6 m -100.19 -28.65 12.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 2.1 p -72.2 -45.69 60.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.306 0.575 . . . . 0.0 110.65 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.61 -32.87 73.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.138 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.68 65.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.514 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 -52.19 1.31 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.586 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -69.5 -33.4 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.319 . . . . 0.0 111.314 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -111.29 59.43 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.76 -78.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 2.0 t80 -54.34 -43.75 71.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.849 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -84.62 -13.24 52.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.36 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.26 -45.49 11.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.959 0.409 . . . . 0.0 111.54 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 24' ' ' ILE . 30.3 mt -86.33 3.66 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.176 0.512 . . . . 0.0 112.126 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 4.99 22.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.531 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -145.09 40.15 1.23 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.852 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.889 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -117.91 115.2 24.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.41 127.63 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.37 82.21 14.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.781 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -87.56 -73.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.806 2.337 . . . . 0.0 112.879 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -133.09 51.4 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 0.0 110.812 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.8 t -80.78 -47.9 1.17 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.644 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 84.4 Cg_endo -82.93 -44.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.419 2.079 . . . . 0.0 112.896 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 8.9 t -68.62 -11.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.814 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 6' ' ' LEU . . . -50.21 -27.45 5.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.597 0.236 . . . . 0.0 111.359 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 15' ' ' ALA . 16.2 tt -91.41 22.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.411 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 9' ' ' VAL . 18.4 t-20 -110.85 -33.68 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.382 . . . . 0.0 110.328 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 m -115.72 -21.02 9.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.223 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG13 HD12 ' A' ' 18' ' ' ILE . 11.0 t -94.68 -25.85 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 0.0 111.024 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -73.5 -26.35 60.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.449 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.32 33.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.66 -77.13 1.05 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.959 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.782 HD12 HG13 ' A' ' 14' ' ' VAL . 50.0 mt -56.63 -32.05 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 111.589 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -103.27 64.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.185 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.22 -51.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -55.25 -60.41 3.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.776 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.89 -26.41 67.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.996 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.2 61.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.282 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 24' ' ' ILE . 10.0 mt -87.18 3.48 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.908 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -99.63 3.58 45.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.68 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -102.04 31.28 4.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.003 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.877 0.37 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -87.11 166.89 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.38 -57.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.05 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -43.13 99.26 0.21 Allowed Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.428 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -93.57 39.03 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.132 2.555 . . . . 0.0 112.743 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -148.97 28.86 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.24 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.3 t -90.15 -51.3 0.34 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.081 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 73.2 Cg_endo -90.57 14.8 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.781 2.321 . . . . 0.0 112.611 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.21 -22.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.567 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.54 -41.99 31.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.251 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -88.28 19.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.474 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -113.58 -32.11 6.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.008 0.432 . . . . 0.0 110.012 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 m -117.08 -20.0 9.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.488 HG12 HD12 ' A' ' 18' ' ' ILE . 4.4 t -97.15 -28.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.964 0.411 . . . . 0.0 110.626 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 11' ' ' ILE . . . -76.58 -33.64 58.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.988 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . -73.71 -21.91 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.471 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.89 -51.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.752 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD12 HG12 ' A' ' 14' ' ' VAL . 25.6 mt -76.26 -43.41 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.0 111.679 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.633 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -117.76 71.22 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.312 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.87 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -56.56 -60.62 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -58.42 -27.24 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.73 -46.89 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 24' ' ' ILE . 33.7 mt -85.31 3.4 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.895 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -108.46 4.49 24.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.697 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 37.96 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.802 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.742 0.306 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.24 99.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 1.8 p90 -134.0 -51.11 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.517 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 1.4 m95 -104.44 170.28 6.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 4' ' ' TRP . 2.7 Cg_endo -42.25 -75.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.304 2.669 . . . . 0.0 112.573 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -165.53 38.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.577 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 21.0 t -60.23 -53.07 68.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.935 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 14.5 Cg_endo -57.35 -51.37 8.64 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.358 2.038 . . . . 0.0 112.76 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' HB ' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t -73.78 -9.66 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.768 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -21.41 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.561 0.219 . . . . 0.0 111.43 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 14' ' ' VAL . 10.4 tt -85.24 10.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.799 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.97 -30.63 8.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.285 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 m -98.04 -27.68 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.652 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG2' HD12 ' A' ' 18' ' ' ILE . 1.4 p -72.93 -44.35 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.21 0.528 . . . . 0.0 110.616 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -66.59 -32.88 74.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -76.26 -20.05 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.82 -71.93 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.856 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.489 HD12 ' CG2' ' A' ' 14' ' ' VAL . 35.9 mt -61.3 -39.23 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -97.3 40.35 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.704 HD13 ' HA ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -149.56 -57.3 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -54.27 -55.38 28.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.787 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -59.1 -27.02 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.62 -49.47 53.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.885 0.374 . . . . 0.0 110.977 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 24' ' ' ILE . 23.3 mt -86.52 3.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.751 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 5.2 41.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.601 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 43.44 0.31 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.937 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.842 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 133.07 38.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -163.17 -79.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.777 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.434 ' CE3' ' HB ' ' A' ' 7' ' ' VAL . 7.8 m0 -112.56 136.71 21.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.722 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.58 -86.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.029 . . . . 0.0 112.303 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -125.46 43.23 3.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.545 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.3 t -86.64 -47.16 0.53 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 35.8 Cg_exo -59.69 -29.83 90.69 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.222 1.948 . . . . 0.0 111.884 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -75.21 -35.77 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.72 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . 3.6 pt -87.74 23.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 111.691 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -115.32 -33.56 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 110.216 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -116.92 -16.25 10.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.225 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG13 ' CG1' ' A' ' 18' ' ' ILE . 8.7 t -103.79 -32.12 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.939 0.399 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . . . -70.73 -35.18 72.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.037 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.41 -24.15 34.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.73 -67.33 0.85 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.492 ' CG1' HG13 ' A' ' 14' ' ' VAL . 33.8 mm -63.86 -40.18 88.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.914 0.387 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.68 57.55 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.986 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.404 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -175.38 -52.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -57.25 -54.12 50.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -66.61 -29.6 69.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.93 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 24' ' ' ILE . 28.2 mt -87.09 3.97 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.798 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.61 4.91 10.6 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.477 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.06 42.51 1.31 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.808 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.92 179.933 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.0 tttm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.804 0.335 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.466 ' HD2' HG21 ' A' ' 9' ' ' VAL . 13.1 ttp180 -130.97 127.73 38.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.776 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.07 -50.42 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 2.2 m95 -79.91 169.75 18.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.991 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 4' ' ' TRP . 1.1 Cg_endo -40.98 -72.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.412 2.742 . . . . 0.0 112.521 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -164.37 34.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 12.3 t -73.44 -48.19 7.17 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.449 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 91.9 Cg_endo -78.54 -22.95 8.91 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.276 1.984 . . . . 0.0 112.598 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG21 ' HD2' ' A' ' 2' ' ' ARG . 3.7 t -94.82 -14.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.59 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -56.28 -31.75 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.624 0.25 . . . . 0.0 111.279 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.39 12.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -105.98 -28.09 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.963 0.411 . . . . 0.0 110.257 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -114.69 -27.78 7.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 18' ' ' ILE . 20.1 t -86.37 -26.35 6.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 111.002 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.38 75.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -68.69 -31.31 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.25 -66.58 1.25 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.644 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.523 HD12 ' CG1' ' A' ' 14' ' ' VAL . 45.7 mt -66.58 -54.76 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -84.74 57.01 4.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.11 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.71 HD23 ' CD1' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -175.79 -64.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -49.03 -64.03 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.709 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.71 -18.53 60.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 20' ' ' LEU . . . -75.5 -52.46 10.62 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.964 0.412 . . . . 0.0 111.416 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.71 ' CD1' HD23 ' A' ' 20' ' ' LEU . 3.6 mt -86.65 3.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.044 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 5.2 tpm_? -105.73 4.52 30.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -137.22 46.22 2.17 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.941 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.813 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 tttp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -106.35 -168.16 1.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 t80 62.44 74.07 0.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -49.84 102.21 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.463 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.94 -66.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.747 2.298 . . . . 0.0 112.281 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 4.4 tp -141.9 32.72 1.58 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.864 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -58.98 -48.83 96.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.824 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.5 -44.77 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.504 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 9' ' ' VAL . 21.8 t -80.47 -2.84 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.654 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -53.68 -27.02 25.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.572 0.225 . . . . 0.0 111.427 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mp -86.65 15.11 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.703 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' HB3' HG12 ' A' ' 9' ' ' VAL . 17.5 t-20 -108.84 -33.89 6.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -106.72 -26.12 11.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.543 ' HA ' HD13 ' A' ' 18' ' ' ILE . 15.8 t -90.99 -20.27 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -93.0 -2.38 55.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.699 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.05 -63.36 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.358 . . . . 0.0 111.561 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.67 -61.45 0.91 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.848 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 14' ' ' VAL . 3.4 mp -46.14 -37.76 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . 11.8 t-20 -96.33 30.63 2.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.68 -63.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.599 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 3.6 t80 -57.97 -49.05 78.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -67.33 -26.94 66.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.77 66.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.017 0.437 . . . . 0.0 110.877 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 24' ' ' ILE . 21.7 mt -87.18 3.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.811 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -115.95 4.69 13.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.572 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.98 37.26 0.95 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.824 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.877 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.766 0.317 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -102.8 -178.58 3.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 -34.73 9.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.771 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -156.6 68.79 4.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.39 64.1 4.49 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.583 2.189 . . . . 0.0 112.117 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -156.92 36.51 0.3 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.2 t -72.55 -47.4 9.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.8 Cg_exo -70.68 -38.47 5.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.561 2.174 . . . . 0.0 112.236 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.69 -2.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.616 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -72.18 0.95 8.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.34 12.48 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 111.191 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -112.91 -34.15 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -117.96 -11.06 10.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 39.5 t -106.68 -17.29 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.829 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -72.62 -35.6 67.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.95 -40.47 31.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.06 73.01 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.424 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.8 mt -95.59 -35.28 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 120.744 0.307 . . . . 0.0 111.556 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -117.49 60.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.17 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.35 -58.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.67 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.78 -19.06 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.97 26.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.536 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 24' ' ' ILE . 28.1 mm -120.69 4.54 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.103 0.477 . . . . 0.0 111.938 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.2 4.4 9.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.576 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 35.74 0.78 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.03 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.98 179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.772 0.32 . . . . 0.0 110.91 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.49 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.9 t -77.83 -48.13 2.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.772 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 82.6 Cg_endo -78.01 -18.21 13.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.237 1.958 . . . . 0.0 112.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' A' ' 6' ' ' LEU . 16.9 t -99.17 -2.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -55.78 -22.75 25.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.656 0.265 . . . . 0.0 111.489 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 11' ' ' ILE . 21.5 mt -87.08 12.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.727 0.299 . . . . 0.0 111.78 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -108.05 -29.05 9.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 110.268 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -109.99 -26.69 9.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' ALA . 25.7 t -87.73 -29.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.22 73.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.28 85.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.247 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.422 -180.0 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 9' ' ' VAL . 7.9 tp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.818 0.342 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.5 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.6 t -77.26 -47.72 2.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.97 -2.68 12.89 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.249 1.966 . . . . 0.0 112.983 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 6' ' ' LEU . 1.9 t -98.89 -35.69 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -28.95 14.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.2 mt -90.17 17.39 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -106.96 -31.6 8.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.888 0.375 . . . . 0.0 110.436 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -117.73 -22.12 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.308 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.8 -23.97 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -66.91 -42.59 85.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.1 90.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.264 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.554 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 tp . . . . . 0 N--CA 1.459 -0.021 0 CA-C-O 120.779 0.323 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.5 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 19.9 t -59.08 -48.23 96.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.85 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 70.9 Cg_endo -75.76 -45.74 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.162 1.908 . . . . 0.0 112.755 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.8 -11.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.692 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -54.87 -34.78 63.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 11' ' ' ILE . 13.8 mm -87.03 14.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.812 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.97 -30.73 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.403 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.3 m -114.71 -19.58 11.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.275 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 10' ' ' ALA . 7.7 t -96.69 -23.99 4.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.854 0.359 . . . . 0.0 111.023 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.92 82.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.56 -18.31 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.735 -179.735 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.768 0.318 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 39.6 t -73.62 -49.32 6.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.504 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 66.2 Cg_endo -74.03 -25.95 13.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.241 1.961 . . . . 0.0 112.322 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.97 -20.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.211 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.72 4.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.2 pt -87.01 15.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.43 -31.84 8.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.421 . . . . 0.0 110.096 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -109.89 -28.54 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.677 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 -27.8 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -72.65 -35.3 67.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.45 76.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.301 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.762 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.6 t -79.69 -48.16 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.7 Cg_exo -71.01 -28.9 18.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.637 2.225 . . . . 0.0 112.142 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.9 t -92.62 -6.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.699 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.88 -24.57 16.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 111.368 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.2 tt -85.03 10.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.676 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.12 -31.64 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 110.053 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.6 m -104.99 -28.06 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 10' ' ' ALA . 31.7 t -88.4 -26.79 5.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -78.66 -32.88 47.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.15 -8.95 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.706 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.349 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.713 -179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.933 0.397 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 t -64.46 -54.35 38.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.717 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 11.9 Cg_endo -55.58 -21.78 32.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.294 1.996 . . . . 0.0 112.751 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.6 -31.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.238 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -49.85 -35.17 22.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 mp -91.67 20.41 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -108.26 -36.18 6.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.509 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 m -121.19 -12.73 8.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 2.8 t -104.96 -16.58 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -75.54 -31.6 60.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.91 -25.53 30.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.538 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.927 -179.657 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t -77.03 -48.24 2.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.411 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 89.1 Cg_endo -81.85 -26.04 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.376 2.051 . . . . 0.0 112.519 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.0 -36.56 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.065 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -51.61 -36.36 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -83.71 10.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.588 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -107.41 -31.6 8.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.041 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.8 m -107.58 -27.13 10.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.676 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' ALA . 15.0 t -91.22 -3.53 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.078 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.69 -38.31 5.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.2 63.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.381 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.575 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.862 0.363 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 t -86.69 -48.61 0.5 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 62.8 Cg_endo -88.8 14.3 2.3 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.724 2.283 . . . . 0.0 112.897 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.99 -26.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.589 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.27 -36.29 30.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.6 mp -84.74 12.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -106.33 -31.56 8.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 110.15 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 m -110.34 -27.58 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.711 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 18.9 t -89.26 -26.31 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -79.65 -11.87 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.644 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.51 -31.75 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 111.519 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.805 -179.761 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.654 0.264 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t -82.17 -48.84 0.9 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 98.1 Cg_endo -84.47 -26.46 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.076 . . . . 0.0 112.438 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.54 -29.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -50.68 -42.85 57.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.24 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 2.1 mp -84.18 9.7 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.619 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.65 -29.75 8.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.224 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 m -113.36 -23.13 10.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 10' ' ' ALA . 6.4 t -96.59 -25.8 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.7 74.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.84 -38.81 53.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.328 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.576 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.954 0.407 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -66.92 -52.36 32.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.814 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 25.6 Cg_endo -62.06 -15.82 46.16 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.639 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.56 -28.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.62 -36.73 36.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.273 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 pt -84.7 12.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.779 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -107.95 -31.82 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.419 . . . . 0.0 110.105 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -109.94 -25.03 10.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.76 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 14.3 t -94.26 -28.44 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.954 0.407 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -76.54 -38.72 54.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 -19.69 59.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.567 -179.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 4.8 t -83.41 -45.01 0.83 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.622 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 25.8 Cg_exo -62.56 -39.87 41.89 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.537 2.158 . . . . 0.0 112.57 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.64 -5.46 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.816 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -58.09 -21.21 45.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.251 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.4 mp -89.33 13.46 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -108.86 -28.94 8.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.549 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -106.16 -25.72 11.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER -82.08 -40.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.154 0.502 . . . . 0.0 110.557 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.46 -29.85 70.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.12 -27.15 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.611 -179.822 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.1 t -85.2 -46.55 0.64 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.447 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 16.7 Cg_exo -67.5 -25.33 41.38 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.511 2.14 . . . . 0.0 112.38 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.93 -45.7 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -48.27 -47.4 36.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.244 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -83.06 12.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.632 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.42 -31.53 9.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.153 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -117.57 -24.76 7.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.224 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 10' ' ' ALA . 13.1 t -88.06 -21.43 7.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -60.8 -43.06 98.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.13 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.101 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.813 0.339 . . . . 0.0 110.77 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 18.0 t -80.73 -47.63 1.2 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 73.0 Cg_endo -76.88 -19.93 13.68 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.227 1.951 . . . . 0.0 112.656 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.78 -27.3 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.01 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.798 0.333 . . . . 0.0 111.288 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.3 mt -85.49 6.6 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.68 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -108.64 -27.43 9.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.338 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.6 m -100.19 -28.65 12.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 2.1 p -72.2 -45.69 60.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.306 0.575 . . . . 0.0 110.65 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.468 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.61 -32.87 73.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.138 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.68 65.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.514 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.586 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.983 0.42 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.8 t -80.78 -47.9 1.17 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.644 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 84.4 Cg_endo -82.93 -44.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.419 2.079 . . . . 0.0 112.896 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 8.9 t -68.62 -11.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.814 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 6' ' ' LEU . . . -50.21 -27.45 5.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.597 0.236 . . . . 0.0 111.359 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 15' ' ' ALA . 16.2 tt -91.41 22.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.411 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 9' ' ' VAL . 18.4 t-20 -110.85 -33.68 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.382 . . . . 0.0 110.328 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 m -115.72 -21.02 9.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.223 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 11.0 t -94.68 -25.85 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 0.0 111.024 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -73.5 -26.35 60.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.449 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.32 33.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.959 -179.616 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.671 0.272 . . . . 0.0 111.24 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.3 t -90.15 -51.3 0.34 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.081 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 73.2 Cg_endo -90.57 14.8 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.781 2.321 . . . . 0.0 112.611 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.21 -22.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.567 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.54 -41.99 31.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.251 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -88.28 19.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.474 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -113.58 -32.11 6.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.008 0.432 . . . . 0.0 110.012 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 m -117.08 -20.0 9.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 4.4 t -97.15 -28.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.964 0.411 . . . . 0.0 110.626 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 11' ' ' ILE . . . -76.58 -33.64 58.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.988 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.71 -21.91 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.471 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.752 -179.744 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.905 0.383 . . . . 0.0 110.826 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.577 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 21.0 t -60.23 -53.07 68.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.935 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 14.5 Cg_endo -57.35 -51.37 8.64 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.358 2.038 . . . . 0.0 112.76 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' HB ' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t -73.78 -9.66 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.768 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -21.41 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.561 0.219 . . . . 0.0 111.43 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 14' ' ' VAL . 10.4 tt -85.24 10.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.799 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.97 -30.63 8.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.285 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 m -98.04 -27.68 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.652 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 1.4 p -72.93 -44.35 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.21 0.528 . . . . 0.0 110.616 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -66.59 -32.88 74.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.26 -20.05 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.345 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.856 -179.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.545 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.3 t -86.64 -47.16 0.53 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 35.8 Cg_exo -59.69 -29.83 90.69 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.222 1.948 . . . . 0.0 111.884 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -75.21 -35.77 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.72 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . 3.6 pt -87.74 23.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 111.691 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -115.32 -33.56 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 110.216 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -116.92 -16.25 10.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.225 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.7 t -103.79 -32.12 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.939 0.399 . . . . 0.0 110.817 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . . . -70.73 -35.18 72.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.037 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.41 -24.15 34.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.482 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.895 0.379 . . . . 0.0 111.087 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 12.3 t -73.44 -48.19 7.17 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.449 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 91.9 Cg_endo -78.54 -22.95 8.91 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.276 1.984 . . . . 0.0 112.598 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.82 -14.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.59 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -56.28 -31.75 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.624 0.25 . . . . 0.0 111.279 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.39 12.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -105.98 -28.09 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.963 0.411 . . . . 0.0 110.257 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -114.69 -27.78 7.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 10' ' ' ALA . 20.1 t -86.37 -26.35 6.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 111.002 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.38 75.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.69 -31.31 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.644 -179.777 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 4.4 tp . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.774 0.321 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -58.98 -48.83 96.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.824 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.5 -44.77 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.504 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 9' ' ' VAL . 21.8 t -80.47 -2.84 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.654 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -53.68 -27.02 25.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.572 0.225 . . . . 0.0 111.427 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mp -86.65 15.11 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.703 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' HB3' HG12 ' A' ' 9' ' ' VAL . 17.5 t-20 -108.84 -33.89 6.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -106.72 -26.12 11.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 10' ' ' ALA . 15.8 t -90.99 -20.27 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -93.0 -2.38 55.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.699 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.05 -63.36 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.358 . . . . 0.0 111.561 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.201 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.848 -179.685 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.852 0.358 . . . . 0.0 110.938 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.2 t -72.55 -47.4 9.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.8 Cg_exo -70.68 -38.47 5.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.561 2.174 . . . . 0.0 112.236 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.69 -2.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.616 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -72.18 0.95 8.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.34 12.48 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 111.191 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -112.91 -34.15 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -117.96 -11.06 10.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 39.5 t -106.68 -17.29 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.829 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -72.62 -35.6 67.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.95 -40.47 31.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.424 -179.924 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.889 0.376 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.61 107.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.28 105.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.1 m0 -110.9 98.16 37.12 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.84 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.09 -65.05 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.542 2.161 . . . . 0.0 112.444 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -142.97 32.55 1.38 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.91 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.49 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 17.9 t -77.83 -48.13 2.21 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.772 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 82.6 Cg_endo -78.01 -18.21 13.12 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.237 1.958 . . . . 0.0 112.672 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 ' HB ' HD13 ' A' ' 6' ' ' LEU . 16.9 t -99.17 -2.99 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.742 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -55.78 -22.75 25.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.656 0.265 . . . . 0.0 111.489 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 11' ' ' ILE . 21.5 mt -87.08 12.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.727 0.299 . . . . 0.0 111.78 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -108.05 -29.05 9.19 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.88 0.371 . . . . 0.0 110.268 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -109.99 -26.69 9.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 10' ' ' ALA . 25.7 t -87.73 -29.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.832 0.349 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.22 73.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.134 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.28 85.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.247 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.31 -46.2 93.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.422 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.5 mt -67.36 -37.08 78.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 111.103 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -98.6 38.88 1.3 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.433 HD23 HG12 ' A' ' 24' ' ' ILE . 0.4 OUTLIER -102.3 -37.42 8.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -58.64 -58.54 8.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.027 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -62.88 -30.66 71.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.55 -47.24 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.211 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 24' ' ' ILE . 25.1 mm -85.01 3.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.726 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -120.2 4.84 10.8 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.515 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -165.08 55.58 0.12 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.891 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.4 tttt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.033 179.831 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.861 0.362 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.45 42.3 2.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.843 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -85.56 92.85 8.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.849 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 6.9 t90 -170.35 86.64 0.54 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.991 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.13 58.82 5.73 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.661 2.241 . . . . 0.0 112.417 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.428 HD12 HG21 ' A' ' 9' ' ' VAL . 7.9 tp -163.48 31.37 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.5 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 16.6 t -77.26 -47.72 2.55 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.835 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.97 -2.68 12.89 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.249 1.966 . . . . 0.0 112.983 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 6' ' ' LEU . 1.9 t -98.89 -35.69 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.8 0.333 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.51 -28.95 14.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.102 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.2 mt -90.17 17.39 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.192 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -106.96 -31.6 8.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.888 0.375 . . . . 0.0 110.436 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.4 m -117.73 -22.12 8.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.308 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.8 -23.97 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.934 0.397 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -66.91 -42.59 85.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.362 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.617 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -65.93 -42.1 90.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.264 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.63 -58.49 7.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.554 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.6 mm -62.06 -34.04 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.088 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -100.73 49.29 0.89 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.04 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -122.07 -66.97 0.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.922 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 2.4 t80 -49.17 -59.55 3.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.702 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -59.71 -23.44 63.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.932 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 20' ' ' LEU . . . -74.28 -46.59 40.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.945 0.402 . . . . 0.0 111.035 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.58 HG22 ' O ' ' A' ' 24' ' ' ILE . 28.3 mm -89.07 3.62 5.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.932 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 13.1 ttp85 -105.44 3.67 29.85 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.561 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 -113.58 33.16 5.32 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.886 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.792 0.329 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 59.91 36.69 21.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.858 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 60.74 19.89 9.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.193 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.535 ' CD1' HG21 ' A' ' 7' ' ' VAL . 4.0 m0 -126.15 94.59 40.99 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.643 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.78 -46.0 2.85 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.433 2.088 . . . . 0.0 112.549 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.702 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 6.7 tp -168.12 33.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.923 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG21 ' CD1' ' A' ' 4' ' ' TRP . 19.9 t -59.08 -48.23 96.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.85 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 70.9 Cg_endo -75.76 -45.74 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.162 1.908 . . . . 0.0 112.755 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.9 t -75.8 -11.25 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.692 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -54.87 -34.78 63.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 111.372 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 11' ' ' ILE . 13.8 mm -87.03 14.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.812 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.97 -30.73 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.944 0.402 . . . . 0.0 110.403 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.3 m -114.71 -19.58 11.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.275 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 18' ' ' ILE . 7.7 t -96.69 -23.99 4.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.854 0.359 . . . . 0.0 111.023 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.92 82.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.56 -18.31 38.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.321 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.64 -68.66 1.12 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.735 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.535 HD12 ' CG1' ' A' ' 14' ' ' VAL . 25.6 mt -70.74 -37.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.69 0.281 . . . . 0.0 111.653 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -104.14 64.34 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.916 0.389 . . . . 0.0 111.251 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -178.09 -44.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -55.85 -58.52 7.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.864 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.31 -29.08 46.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.045 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.27 -49.11 59.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.182 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 24' ' ' ILE . 27.9 mt -86.69 3.36 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.842 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -105.32 4.83 31.35 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.562 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -138.62 50.96 1.84 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.997 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.915 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 N--CA 1.487 1.417 0 CA-C-O 120.784 0.325 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -74.51 108.16 7.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -86.46 131.77 34.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.792 ' O ' HG23 ' A' ' 7' ' ' VAL . 1.8 t90 -116.68 88.28 24.34 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.909 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.21 2.26 8.6 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.717 2.278 . . . . 0.0 112.911 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.7 32.49 6.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.768 0.318 . . . . 0.0 111.048 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 4' ' ' TRP . 39.6 t -73.62 -49.32 6.44 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.504 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 66.2 Cg_endo -74.03 -25.95 13.48 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.241 1.961 . . . . 0.0 112.322 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -78.97 -20.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.211 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.93 -26.72 4.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.802 0.334 . . . . 0.0 111.429 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 2.2 pt -87.01 15.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.669 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.43 -31.84 8.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.985 0.421 . . . . 0.0 110.096 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.1 m -109.89 -28.54 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.677 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.44 -27.8 5.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -72.65 -35.3 67.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.45 76.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.301 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -54.47 -22.88 25.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.762 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mt -123.01 -36.28 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -110.27 68.21 0.66 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.943 0.401 . . . . 0.0 111.275 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -152.8 -50.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.689 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -59.18 -51.86 68.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -65.35 -28.95 69.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.961 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.43 22.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 24' ' ' ILE . 4.8 mt -85.45 3.41 3.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.582 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -117.72 4.83 12.28 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.461 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.53 54.75 0.38 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.278 -0.867 . . . . 0.0 110.849 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.798 0.332 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.36 99.7 6.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.922 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -121.85 94.2 4.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -168.33 74.82 0.85 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.36 63.57 0.51 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.862 2.374 . . . . 0.0 112.298 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.5 tp -168.18 32.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.977 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.6 t -79.69 -48.16 1.44 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.203 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.7 Cg_exo -71.01 -28.9 18.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.637 2.225 . . . . 0.0 112.142 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 9' ' ' VAL . 22.9 t -92.62 -6.3 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.699 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -53.88 -24.57 16.44 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.677 0.275 . . . . 0.0 111.368 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 15.2 tt -85.03 10.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.676 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.12 -31.64 8.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.936 0.398 . . . . 0.0 110.053 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 79.6 m -104.99 -28.06 11.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.59 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 10' ' ' ALA . 31.7 t -88.4 -26.79 5.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -78.66 -32.88 47.41 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.15 -8.95 59.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.706 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.94 -76.28 0.99 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.713 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.2 mt -68.98 -29.05 41.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.623 0.249 . . . . 0.0 111.519 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -110.9 49.72 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 111.237 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.88 -61.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.088 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -52.29 -56.34 15.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.925 0.393 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.15 -23.05 63.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.249 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.56 -44.92 26.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.871 0.367 . . . . 0.0 111.282 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 24' ' ' ILE . 30.3 mt -86.95 4.03 4.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.969 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.76 4.0 10.58 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.725 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.29 43.23 3.1 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.833 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.86 0.362 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.82 54.94 1.17 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.888 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.53 141.09 5.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.017 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 t90 51.97 68.19 3.41 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.027 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.94 61.23 3.82 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.685 2.257 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -160.63 33.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.727 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.4 t -64.46 -54.35 38.32 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.717 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 11.9 Cg_endo -55.58 -21.78 32.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.294 1.996 . . . . 0.0 112.751 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.6 -31.09 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.779 0.323 . . . . 0.0 111.238 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -49.85 -35.17 22.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 15' ' ' ALA . 1.1 mp -91.67 20.41 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.375 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -108.26 -36.18 6.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.833 0.349 . . . . 0.0 110.509 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.0 m -121.19 -12.73 8.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.504 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 18' ' ' ILE . 2.8 t -104.96 -16.58 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.784 0.326 . . . . 0.0 111.001 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.571 ' HB2' ' CG2' ' A' ' 11' ' ' ILE . . . -75.54 -31.6 60.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.36 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.91 -25.53 30.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.538 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.54 -74.74 1.14 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.927 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.519 ' HB ' HG12 ' A' ' 14' ' ' VAL . 39.9 mm -62.64 -34.59 66.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.662 0.268 . . . . 0.0 111.506 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -103.45 51.59 0.79 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.902 0.382 . . . . 0.0 111.187 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' C ' HD13 ' A' ' 20' ' ' LEU . 2.8 tm? -146.59 -71.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.894 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.402 ' O ' ' CB ' ' A' ' 25' ' ' ARG . 2.8 t80 -58.38 -44.31 88.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.914 0.388 . . . . 0.0 110.529 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -76.89 -21.57 54.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.195 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.35 -51.04 16.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.891 0.377 . . . . 0.0 111.488 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.2 mt -85.75 3.77 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.976 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 4.7 ttt85 -125.32 4.95 7.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.665 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.47 36.72 0.23 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.155 -0.926 . . . . 0.0 110.908 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.885 0.374 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -89.51 169.84 11.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.951 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.68 -166.43 0.2 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.81 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 7' ' ' VAL . 6.0 t90 -111.17 83.24 3.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.28 4.84 6.67 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.736 2.291 . . . . 0.0 112.865 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -108.33 34.38 3.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 4' ' ' TRP . 8.5 t -77.03 -48.24 2.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.411 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 89.1 Cg_endo -81.85 -26.04 3.23 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.376 2.051 . . . . 0.0 112.519 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -81.0 -36.56 15.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.065 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -51.61 -36.36 45.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.3 tt -83.71 10.1 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.588 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -107.41 -31.6 8.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.041 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.8 m -107.58 -27.13 10.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.676 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 10' ' ' ALA . 15.0 t -91.22 -3.53 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.078 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.69 -38.31 5.91 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.95 -25.2 63.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.381 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -100.52 -52.57 1.12 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.575 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.5 mm -68.61 -34.06 63.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.546 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -121.57 72.72 1.02 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.182 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.76 -44.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.931 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -62.14 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.87 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.01 -20.35 60.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.31 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -79.74 -47.03 15.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.919 0.39 . . . . 0.0 111.348 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 24' ' ' ILE . 23.6 mm -87.07 3.9 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.189 0.519 . . . . 0.0 111.917 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -127.4 4.93 6.27 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.838 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.33 54.04 0.11 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 tttt . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.888 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.902 0.382 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -127.32 137.49 52.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -102.13 -53.92 2.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.839 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.401 ' HB3' ' HD3' ' A' ' 8' ' ' PRO . 22.5 m0 -76.01 118.76 73.55 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.591 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.11 -42.96 0.42 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.448 2.099 . . . . 0.0 112.885 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.89 40.62 0.19 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.307 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.501 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 t -86.69 -48.61 0.5 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.337 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 62.8 Cg_endo -88.8 14.3 2.3 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.724 2.283 . . . . 0.0 112.897 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.99 -26.15 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.589 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.27 -36.29 30.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.367 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.6 mp -84.74 12.43 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.685 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -106.33 -31.56 8.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.076 0.465 . . . . 0.0 110.15 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.7 m -110.34 -27.58 8.99 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.711 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 18.9 t -89.26 -26.31 5.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.625 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -79.65 -11.87 59.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.644 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.51 -31.75 18.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 111.519 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -114.67 -68.78 0.47 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.805 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.9 mm -56.21 -29.89 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.451 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -122.2 61.69 0.96 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.993 0.425 . . . . 0.0 111.145 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD23 HD12 ' A' ' 24' ' ' ILE . 1.0 OUTLIER -176.38 -57.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.038 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.26 -63.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 0.0 110.725 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -21.66 65.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.19 -36.42 61.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.743 0.306 . . . . 0.0 111.241 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.574 HG22 ' O ' ' A' ' 24' ' ' ILE . 29.2 mt -99.81 3.43 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.107 0.479 . . . . 0.0 111.98 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.05 3.92 49.3 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.654 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -112.2 33.69 4.72 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.945 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.923 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 120.87 0.367 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.46 103.46 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.81 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -79.39 87.0 5.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.439 ' CD1' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -169.2 131.98 1.15 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.755 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.439 ' HD2' ' CD1' ' A' ' 4' ' ' TRP . 73.7 Cg_endo -90.37 31.96 0.35 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.82 2.347 . . . . 0.0 112.801 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -155.87 31.19 0.36 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.039 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.499 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.9 t -82.17 -48.84 0.9 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 98.1 Cg_endo -84.47 -26.46 1.71 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.413 2.076 . . . . 0.0 112.438 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.54 -29.71 44.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.365 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -50.68 -42.85 57.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.24 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 11' ' ' ILE . 2.1 mp -84.18 9.7 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.619 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -107.65 -29.75 8.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.999 0.428 . . . . 0.0 110.224 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.1 m -113.36 -23.13 10.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.034 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 10' ' ' ALA . 6.4 t -96.59 -25.8 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 CA-C-O 120.918 0.39 . . . . 0.0 111.018 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.12 -32.7 74.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.17 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB1' HD22 ' A' ' 20' ' ' LEU . . . -76.84 -38.81 53.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.328 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -57.15 -27.41 57.46 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.576 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.1 mt -113.27 -30.65 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-O 120.697 0.284 . . . . 0.0 111.719 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.34 72.72 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.132 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 HD22 ' HB1' ' A' ' 16' ' ' ALA . 2.6 tp -162.1 -48.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.674 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.95 -54.14 48.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.98 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -62.34 -30.23 71.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.987 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.62 -45.95 60.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.197 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 24' ' ' ILE . 30.2 mm -85.61 3.65 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.757 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.44 4.99 13.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.529 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -163.22 53.68 0.18 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.972 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.144 -0.931 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.3 tptt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.802 0.334 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -108.25 95.97 6.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -91.38 -26.88 18.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.921 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.459 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.1 OUTLIER -56.14 115.5 9.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.83 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.92 44.32 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.588 2.192 . . . . 0.0 112.712 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -167.24 32.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.757 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -66.92 -52.36 32.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.814 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 25.6 Cg_endo -62.06 -15.82 46.16 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.186 1.924 . . . . 0.0 112.639 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.56 -28.55 2.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.806 0.336 . . . . 0.0 111.168 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -50.62 -36.73 36.58 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.273 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.614 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.8 pt -84.7 12.74 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.779 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -107.95 -31.82 7.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.419 . . . . 0.0 110.105 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -109.94 -25.03 10.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.76 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 14.3 t -94.26 -28.44 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.954 0.407 . . . . 0.0 110.89 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -76.54 -38.72 54.6 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.091 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 -19.69 59.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.382 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -92.16 -61.63 1.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.567 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 mm -67.84 -36.88 77.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.79 65.66 0.76 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.091 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -174.87 -40.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -69.71 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.792 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -56.41 -22.79 34.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.91 -61.94 1.78 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 24' ' ' ILE . 25.4 mm -85.7 3.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.947 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 ttm180 -107.63 5.21 26.68 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.611 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.91 44.7 0.44 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.979 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.217 -0.896 . . . . 0.0 110.942 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.0 tttt . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.762 0.315 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.38 134.26 0.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.866 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 62.41 86.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -120.88 60.5 8.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.711 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.32 -77.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.712 2.275 . . . . 0.0 112.775 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.669 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -123.97 46.59 2.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 111.09 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.495 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 4.8 t -83.41 -45.01 0.83 Allowed Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.622 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 25.8 Cg_exo -62.56 -39.87 41.89 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.537 2.158 . . . . 0.0 112.57 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -92.64 -5.46 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.816 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -58.09 -21.21 45.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.251 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.4 mp -89.33 13.46 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.751 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -108.86 -28.94 8.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.824 0.345 . . . . 0.0 110.549 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -106.16 -25.72 11.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.752 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -82.08 -40.49 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.154 0.502 . . . . 0.0 110.557 179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.46 -29.85 70.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.24 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' O ' HD13 ' A' ' 20' ' ' LEU . . . -83.12 -27.15 30.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.262 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -104.06 -70.37 0.81 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.611 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 14' ' ' VAL . 39.3 mm -58.64 -42.74 85.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 111.271 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -94.5 60.94 2.67 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.978 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -165.09 -46.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.841 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.71 -57.38 13.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.868 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -65.01 -28.75 69.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.959 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.81 -48.4 66.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.926 0.393 . . . . 0.0 111.095 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 24' ' ' ILE . 27.2 mm -86.88 4.06 4.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.731 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.52 4.53 9.6 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.63 36.83 1.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.766 0.317 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -114.07 119.93 38.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -164.86 158.38 17.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -131.06 86.94 50.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.78 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.52 52.26 4.26 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.207 2.605 . . . . 0.0 112.352 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -171.29 32.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.84 0.352 . . . . 0.0 111.146 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 4' ' ' TRP . 3.1 t -85.2 -46.55 0.64 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.447 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 16.7 Cg_exo -67.5 -25.33 41.38 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.511 2.14 . . . . 0.0 112.38 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.93 -45.7 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.359 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 14' ' ' VAL . . . -48.27 -47.4 36.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.244 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.615 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -83.06 12.06 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.632 179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.42 -31.53 9.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.9 0.381 . . . . 0.0 110.153 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -117.57 -24.76 7.16 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.224 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.51 HG12 ' CD1' ' A' ' 18' ' ' ILE . 13.1 t -88.06 -21.43 7.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.615 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -60.8 -43.06 98.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.048 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.584 ' O ' HD12 ' A' ' 20' ' ' LEU . . . -65.76 -33.13 75.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.101 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.92 -49.62 8.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.544 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' CD1' HG12 ' A' ' 14' ' ' VAL . 60.1 mt -63.97 -40.25 88.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.37 . . . . 0.0 111.22 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -90.65 59.47 4.23 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.102 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.584 HD12 ' O ' ' A' ' 16' ' ' ALA . 0.3 OUTLIER -174.25 -43.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.925 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.34 -55.42 35.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.042 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -60.15 -31.48 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.94 -44.63 63.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.052 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 24' ' ' ILE . 22.2 mt -86.48 3.3 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.718 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -128.89 5.46 5.44 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.551 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -156.87 37.13 0.3 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.809 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.983 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.818 0.342 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.7 mtm-85 -139.88 166.35 24.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.995 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.64 112.98 16.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.847 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -148.46 73.14 10.81 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.12 62.42 0.65 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.827 2.351 . . . . 0.0 112.438 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -165.35 30.85 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.77 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 18.0 t -80.73 -47.63 1.2 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.89 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 73.0 Cg_endo -76.88 -19.93 13.68 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.227 1.951 . . . . 0.0 112.656 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 t -84.78 -27.3 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.052 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.32 -26.01 11.08 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.798 0.333 . . . . 0.0 111.288 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 11' ' ' ILE . 3.3 mt -85.49 6.6 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.68 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -108.64 -27.43 9.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.338 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.6 m -100.19 -28.65 12.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.752 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 15' ' ' ALA . 2.1 p -72.2 -45.69 60.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.306 0.575 . . . . 0.0 110.65 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.468 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -62.61 -32.87 73.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.138 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.68 65.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.514 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -98.78 -52.19 1.31 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.586 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.6 mt -69.5 -33.4 56.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.319 . . . . 0.0 111.314 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -111.29 59.43 0.61 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 178.76 -78.62 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 2.0 t80 -54.34 -43.75 71.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.849 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 ttpp -84.62 -13.24 52.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.36 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.26 -45.49 11.23 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.959 0.409 . . . . 0.0 111.54 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 24' ' ' ILE . 30.3 mt -86.33 3.66 4.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.176 0.512 . . . . 0.0 112.126 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -109.86 4.99 22.16 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.531 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -145.09 40.15 1.23 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.852 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 pttm . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.3 -0.857 . . . . 0.0 110.889 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.756 0.312 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -117.91 115.2 24.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.41 127.63 42.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.005 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -117.37 82.21 14.66 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.781 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -87.56 -73.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.806 2.337 . . . . 0.0 112.879 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -133.09 51.4 2.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 0.0 110.812 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 2.8 t -80.78 -47.9 1.17 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.644 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 84.4 Cg_endo -82.93 -44.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.419 2.079 . . . . 0.0 112.896 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 8.9 t -68.62 -11.7 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.814 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 6' ' ' LEU . . . -50.21 -27.45 5.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.597 0.236 . . . . 0.0 111.359 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.701 HG13 ' HB2' ' A' ' 15' ' ' ALA . 16.2 tt -91.41 22.21 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.411 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' HB3' HG12 ' A' ' 9' ' ' VAL . 18.4 t-20 -110.85 -33.68 6.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.901 0.382 . . . . 0.0 110.328 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.4 m -115.72 -21.02 9.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.223 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG13 HD12 ' A' ' 18' ' ' ILE . 11.0 t -94.68 -25.85 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.877 0.37 . . . . 0.0 111.024 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.701 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -73.5 -26.35 60.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.449 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.32 33.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.624 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -106.66 -77.13 1.05 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.959 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.782 HD12 HG13 ' A' ' 14' ' ' VAL . 50.0 mt -56.63 -32.05 36.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.702 0.287 . . . . 0.0 111.589 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -103.27 64.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.975 0.417 . . . . 0.0 111.185 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.22 -51.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -55.25 -60.41 3.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.776 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -60.89 -26.41 67.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.996 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.2 61.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.907 0.384 . . . . 0.0 111.282 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 24' ' ' ILE . 10.0 mt -87.18 3.48 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.908 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -99.63 3.58 45.3 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.68 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -102.04 31.28 4.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.174 -0.917 . . . . 0.0 111.003 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.877 0.37 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.0 mtt180 -87.11 166.89 14.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -133.38 -57.88 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.05 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -43.13 99.26 0.21 Allowed Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.428 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -93.57 39.03 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.132 2.555 . . . . 0.0 112.743 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -148.97 28.86 0.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.24 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 1.3 t -90.15 -51.3 0.34 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.081 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 73.2 Cg_endo -90.57 14.8 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.781 2.321 . . . . 0.0 112.611 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 t -110.21 -22.73 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.567 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -48.54 -41.99 31.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.876 0.369 . . . . 0.0 111.251 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG23 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -88.28 19.71 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.474 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -113.58 -32.11 6.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.008 0.432 . . . . 0.0 110.012 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.1 m -117.08 -20.0 9.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.211 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.488 HG12 HD12 ' A' ' 18' ' ' ILE . 4.4 t -97.15 -28.93 3.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 120.964 0.411 . . . . 0.0 110.626 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 11' ' ' ILE . . . -76.58 -33.64 58.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.988 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 20' ' ' LEU . . . -73.71 -21.91 60.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.471 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.89 -51.28 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.752 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD12 HG12 ' A' ' 14' ' ' VAL . 25.6 mt -76.26 -43.41 37.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.777 0.322 . . . . 0.0 111.679 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.633 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -117.76 71.22 0.81 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.312 -179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER 175.87 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -56.56 -60.62 3.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -58.42 -27.24 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.73 -46.89 57.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 24' ' ' ILE . 33.7 mt -85.31 3.4 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.895 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -108.46 4.49 24.32 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.697 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.5 37.96 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.802 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.742 0.306 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.24 99.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.926 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.462 ' N ' ' CD1' ' A' ' 3' ' ' PHE . 1.8 p90 -134.0 -51.11 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.517 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 1.4 m95 -104.44 170.28 6.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.802 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 4' ' ' TRP . 2.7 Cg_endo -42.25 -75.84 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.304 2.669 . . . . 0.0 112.573 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -165.53 38.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.826 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.577 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 21.0 t -60.23 -53.07 68.5 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.935 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 14.5 Cg_endo -57.35 -51.37 8.64 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.358 2.038 . . . . 0.0 112.76 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' HB ' ' HG ' ' A' ' 6' ' ' LEU . 2.7 t -73.78 -9.66 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.768 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -21.41 37.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.561 0.219 . . . . 0.0 111.43 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' HA ' HG12 ' A' ' 14' ' ' VAL . 10.4 tt -85.24 10.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.804 0.335 . . . . 0.0 111.799 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -108.97 -30.63 8.0 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.285 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 m -98.04 -27.68 14.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.652 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG2' HD12 ' A' ' 18' ' ' ILE . 1.4 p -72.93 -44.35 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.21 0.528 . . . . 0.0 110.616 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . -66.59 -32.88 74.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -76.26 -20.05 57.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.345 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -107.82 -71.93 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.856 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.489 HD12 ' CG2' ' A' ' 14' ' ' VAL . 35.9 mt -61.3 -39.23 81.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -97.3 40.35 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.704 HD13 ' HA ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -149.56 -57.3 0.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.823 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -54.27 -55.38 28.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 110.787 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.3 tttp -59.1 -27.02 65.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.899 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.62 -49.47 53.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.885 0.374 . . . . 0.0 110.977 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 24' ' ' ILE . 23.3 mt -86.52 3.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.751 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.78 5.2 41.09 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.601 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 43.44 0.31 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.937 179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.842 0.354 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.62 133.07 38.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.017 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -163.17 -79.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.777 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.434 ' CE3' ' HB ' ' A' ' 7' ' ' VAL . 7.8 m0 -112.56 136.71 21.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.722 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.58 -86.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.029 . . . . 0.0 112.303 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -125.46 43.23 3.11 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.545 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.476 ' HB ' ' HD3' ' A' ' 8' ' ' PRO . 5.3 t -86.64 -47.16 0.53 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.468 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 7' ' ' VAL . 35.8 Cg_exo -59.69 -29.83 90.69 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.222 1.948 . . . . 0.0 111.884 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -75.21 -35.77 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.185 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.72 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.252 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 15' ' ' ALA . 3.6 pt -87.74 23.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.813 0.339 . . . . 0.0 111.691 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -115.32 -33.56 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.004 0.431 . . . . 0.0 110.216 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 m -116.92 -16.25 10.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.225 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG13 ' CG1' ' A' ' 18' ' ' ILE . 8.7 t -103.79 -32.12 2.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.939 0.399 . . . . 0.0 110.817 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . . . -70.73 -35.18 72.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.037 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.41 -24.15 34.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.289 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.73 -67.33 0.85 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.492 ' CG1' HG13 ' A' ' 14' ' ' VAL . 33.8 mm -63.86 -40.18 88.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.914 0.387 . . . . 0.0 111.189 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.68 57.55 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.986 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.404 ' CD2' ' CD1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -175.38 -52.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.803 179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -57.25 -54.12 50.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.796 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -66.61 -29.6 69.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.12 -47.93 72.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 111.106 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 24' ' ' ILE . 28.2 mt -87.09 3.97 4.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.798 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.61 4.91 10.6 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.477 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.06 42.51 1.31 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.808 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 tttt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.92 179.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 45.0 tttm . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.804 0.335 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.466 ' HD2' HG21 ' A' ' 9' ' ' VAL . 13.1 ttp180 -130.97 127.73 38.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.776 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.07 -50.42 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.518 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 2.2 m95 -79.91 169.75 18.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.991 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 4' ' ' TRP . 1.1 Cg_endo -40.98 -72.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 123.412 2.742 . . . . 0.0 112.521 179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.615 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -164.37 34.29 0.07 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.489 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 12.3 t -73.44 -48.19 7.17 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.449 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 91.9 Cg_endo -78.54 -22.95 8.91 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.276 1.984 . . . . 0.0 112.598 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG21 ' HD2' ' A' ' 2' ' ' ARG . 3.7 t -94.82 -14.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.59 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -56.28 -31.75 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.624 0.25 . . . . 0.0 111.279 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -87.39 12.31 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.81 -179.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -105.98 -28.09 10.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.963 0.411 . . . . 0.0 110.257 179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.6 m -114.69 -27.78 7.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.942 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 18' ' ' ILE . 20.1 t -86.37 -26.35 6.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-O 120.893 0.377 . . . . 0.0 111.002 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.97 -33.38 75.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.449 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -68.69 -31.31 70.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.25 -66.58 1.25 Allowed Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.644 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.523 HD12 ' CG1' ' A' ' 14' ' ' VAL . 45.7 mt -66.58 -54.76 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.915 0.388 . . . . 0.0 111.387 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -84.74 57.01 4.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.11 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.71 HD23 ' CD1' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -175.79 -64.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.42 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 0.8 OUTLIER -49.03 -64.03 0.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.709 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -61.71 -18.53 60.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 20' ' ' LEU . . . -75.5 -52.46 10.62 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.964 0.412 . . . . 0.0 111.416 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.71 ' CD1' HD23 ' A' ' 20' ' ' LEU . 3.6 mt -86.65 3.33 4.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.044 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 5.2 tpm_? -105.73 4.52 30.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.525 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -137.22 46.22 2.17 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.941 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.813 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 tttp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.856 0.36 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -106.35 -168.16 1.39 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.793 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 t80 62.44 74.07 0.45 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.854 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 4' ' ' TRP . 0.2 OUTLIER -49.84 102.21 0.3 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.463 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.94 -66.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.747 2.298 . . . . 0.0 112.281 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.673 ' O ' ' HB2' ' A' ' 10' ' ' ALA . 4.4 tp -141.9 32.72 1.58 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.864 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' ' HD2' ' A' ' 8' ' ' PRO . 20.8 t -58.98 -48.83 96.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.824 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 7' ' ' VAL . 74.4 Cg_endo -75.5 -44.77 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.223 1.949 . . . . 0.0 112.504 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 9' ' ' VAL . 21.8 t -80.47 -2.84 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.654 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB2' ' O ' ' A' ' 6' ' ' LEU . . . -53.68 -27.02 25.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.572 0.225 . . . . 0.0 111.427 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 11' ' ' ILE . 2.7 mp -86.65 15.11 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.703 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' HB3' HG12 ' A' ' 9' ' ' VAL . 17.5 t-20 -108.84 -33.89 6.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 110.016 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -106.72 -26.12 11.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.543 ' HA ' HD13 ' A' ' 18' ' ' ILE . 15.8 t -90.99 -20.27 6.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.748 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 11' ' ' ILE . . . -93.0 -2.38 55.8 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.699 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.05 -63.36 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.358 . . . . 0.0 111.561 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.67 -61.45 0.91 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.848 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 14' ' ' VAL . 3.4 mp -46.14 -37.76 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' CB ' ' HA ' ' A' ' 15' ' ' ALA . 11.8 t-20 -96.33 30.63 2.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.065 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.68 -63.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.599 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 25' ' ' ARG . 3.6 t80 -57.97 -49.05 78.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -67.33 -26.94 66.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.77 66.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.017 0.437 . . . . 0.0 110.877 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG22 ' O ' ' A' ' 24' ' ' ILE . 21.7 mt -87.18 3.76 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.811 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -115.95 4.69 13.84 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.572 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.98 37.26 0.95 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.824 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.877 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.766 0.317 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -102.8 -178.58 3.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.98 -34.73 9.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.771 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -156.6 68.79 4.63 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.39 64.1 4.49 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.583 2.189 . . . . 0.0 112.117 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -156.92 36.51 0.3 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 3.2 t -72.55 -47.4 9.64 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.156 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' A' ' 7' ' ' VAL . 11.8 Cg_exo -70.68 -38.47 5.74 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.561 2.174 . . . . 0.0 112.236 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.69 -2.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.616 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -72.18 0.95 8.44 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.523 HG13 ' HB2' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -131.34 12.48 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.973 0.416 . . . . 0.0 111.191 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -112.91 -34.15 5.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.107 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 m -117.96 -11.06 10.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.12 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 10' ' ' ALA . 39.5 t -106.68 -17.29 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.829 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -72.62 -35.6 67.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.046 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.95 -40.47 31.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.121 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.06 73.01 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.424 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.8 mt -95.59 -35.28 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 120.744 0.307 . . . . 0.0 111.556 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -117.49 60.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.17 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 178.35 -58.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.67 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.78 -19.06 65.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.276 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.34 -21.97 26.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.536 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 24' ' ' ILE . 28.1 mm -120.69 4.54 6.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.103 0.477 . . . . 0.0 111.938 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.2 4.4 9.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.576 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 35.74 0.78 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.03 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.98 179.931 . . . . . . . . 0 0 . 1 stop_ save_